Acute pancreatitis

K11_ACUTPANC

acute pancreatitis: An acute inflammatory process that leads to necrosis of the pancreatic parenchyma. Signs and symptoms include severe abdominal pain, nausea, vomiting, diarrhea, fever, and shock. Causes include alcohol consumption, presence of gallstones, trauma, and drugs.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K85 Hospital discharge: ICD-9 — 5770 Hospital discharge: ICD-8 — 5770 Cause of death: ICD-10 — K85 Cause of death: ICD-9 — 5770 Cause of death: ICD-8 — 5770 2 out of 7 registries used, show all original rules.	8694
4. Check minimum number of events None	8694
5. Include endpoints None	8694
6. Filter based on genotype QC (FinnGen only)	8694

Control definitions (FinnGen only)

Control exclude: K11_GALLBILPANC

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: K80-K87
Name in latin: Pancreatitis acuta

NAME	K11_ACUTPANC
CONTROL_EXCLUDE	K11_GALLBILPANC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K85
HD_ICD_9	5770
HD_ICD_8	5770
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K85
COD_ICD_9	5770
COD_ICD_8	5770
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Acute pancreatitis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	81729	31416	49217
Only index persons	62108	25645	36463
Unadjusted period prevalence (%)
Whole population	1.19	0.90	1.38
Only index persons	1.21	0.94	1.39
Median age at first event (years)
Whole population	54.14	58.68	51.26
Only index persons	53.87	56.99	51.68

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	8694	3476	5218
Unadjusted period prevalence (%)	1.85	1.18	2.30
Median age at first event (years)	54.39	53.43	55.02

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7809: Matched controls
78095

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

139.1

323.0

471

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

53.2

323.0

765

159

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

303.8

323.0

1838

R10.1

ICD-10 Finland

Pain localized to upper abdomen

5.8

323.0

2284

5175

5770A

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA NONALCOHOLICA NONHAEMORRHAGICA]

+∞

323.0

363

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

104.3

323.0

480

JN3AD

NOMESCO Finland

Abdominal CT examination

7.8

323.0

1523

2360

K85.1

ICD-10 Finland

Biliary acute pancreatitis

+∞

323.0

978

A09AA02

ATC

multienzymes (lipase, protease etc.)

54.5

323.0

741

150

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

705.3

323.0

649

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

5.1

323.0

1960

4799

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

+∞

323.0

717

K83.1

ICD-10 Finland

Obstruction of bile duct

1110.6

323.0

320

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

563.3

323.0

625

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

538.4

323.0

1962

57708

ICD-8 Finland

Diseases of pancreas, Pancreatitis acuta alia

+∞

323.0

367

K86.1

ICD-10 Finland

Other chronic pancreatitis

7915.2

323.0

730

57709

ICD-8 Finland

Diseases of pancreas, Pancreatitis NUD

+∞

323.0

441

K85

ICD-10 Finland

Acute pancreatitis

2119.3

323.0

2567

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

16384.0

323.0

2877

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

97.6

323.0

545

K80.1

ICD-10 Finland

Calculus of gallbladder with other cholecystitis

+∞

323.0

346

K83.0

ICD-10 Finland

Cholangitis

3846.5

323.0

377

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

6777.0

323.0

1179

K85.8

ICD-10 Finland

Other acute pancreatitis

+∞

323.0

842

JN3BD

NOMESCO Finland

Extensive abdominal CT

6.9

323.0

2005

3724

UJK02

NOMESCO Finland

ERCP

107.4

323.0

886

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

1574.6

323.0

438

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

8.3

323.0

1649

2440

K86.3

ICD-10 Finland

Pseudocyst of pancreas

4902.9

323.0

472

5770D

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA ALCOHOLICA NONHAEMORHAGICA]

+∞

323.0

445

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

+∞

323.0

587

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

4.6

323.0

4040

14812

K85.0

ICD-10 Finland

Idiopathic acute pancreatitis

+∞

323.0

889

JKE12

NOMESCO Finland

Endoscopic extraction of calculus from bile duct

1081.6

320.8

312

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.7

314.6

2819

13339

N02AX02

ATC

tramadol; systemic, rectal

2.5

310.1

3934

22598

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

34.9

305.1

401

121

JKA20

NOMESCO Finland

Cholecystectomy

36.5

299.1

389

112

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

4.5

266.6

1051

2622

A02BC02

ATC

pantoprazole; systemic

2.3

264.4

5326

37285

K81.0

ICD-10 Finland

Acute cholecystitis

340.9

264.2

266

K86.9

ICD-10 Finland

Disease of pancreas, unspecified

646.3

254.9

251

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

7.2

251.5

647

966

103

Kela drug reimbursment

Diabetes, insulin-treated

2.5

249.1

2654

13438

TPH04

NOMESCO Finland

Cathetrisation of vein

2.6

235.0

2080

9443

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

60.6

218.8

258

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.4

214.2

2301

11509

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

65.3

212.0

247

K86.01

ICD-10 Finland

Late effects of pancreatitis caused by alcohol

710.4

211.6

208

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

10.2

211.4

436

450

J01MA12

ATC

levofloxacin; systemic

2.6

209.5

1860

8375

A10AE04

ATC

insulin glargine; parenteral

3.4

207.6

1128

3672

JLW98

NOMESCO Finland

Other transluminal endoscopic operation on pancreas

200.9

207.3

215

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

201.7

3724

23728

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

3.8

201.3

933

2664

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.3

196.4

2214

11253

R10.0

ICD-10 Finland

Acute abdomen

7.0

184.0

481

728

T90

ICPC

Diabetes non-insulin dependent

2.3

180.2

2111

10846

K81.9

ICD-10 Finland

Cholecystitis, unspecified

311.2

178.8

181

TJK01

NOMESCO Finland

Laparoscopic cholangiography

+∞

178.8

171

K80.8

ICD-10 Finland

Other cholelithiasis

53.1

171.9

207

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

31.3

171.6

231

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

85.2

170.1

191

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

12.2

167.2

314

268

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.5

166.2

1539

6971

K86.8

ICD-10 Finland

Other specified diseases of pancreas

552.8

164.6

163

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

8.2

162.9

380

483

5770F

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA ALCOHOLICA RECIDIVANS]

+∞

156.8

150

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.5

156.4

595

1402

K80.3

ICD-10 Finland

Calculus of bile duct with cholangitis

778.5

155.9

153

K86.2

ICD-10 Finland

Cyst of pancreas

773.3

154.9

152

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

6.1

150.4

435

751

A10BA02

ATC

metformin; oral

2.0

150.1

2405

13972

K80.4

ICD-10 Finland

Calculus of bile duct with cholecystitis

504.0

150.1

149

WX408

NOMESCO Finland

General anesthesy, balanced

2.1

146.7

2221

12580

N02BE01

ATC

paracetamol; systemic, rectal

2.1

144.0

6527

55063

D02

ICPC

Abdominal pain epigastric

4.2

141.2

582

1477

N07BB01

ATC

disulfiram; oral

4.0

137.8

600

1600

XF400

NOMESCO Finland

ECG with 12 standard connections

2.2

133.4

1536

7663

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

7.5

127.6

315

436

JKE22

NOMESCO Finland

Endoscopic extraction of foreign body from bile duct

264.9

127.5

130

F10.25

ICD-10 Finland

Alcohol dependence continuous use

6.5

124.2

339

541

5742A

ICD-9 Finland

Cholelithiasis, Calculus of gallbladder without mention of cholecystitis[CHOLECYSTOLITHIASIS SINE CHOLECYSTITIDE,SINE OBSTR]

+∞

123.2

118

A02BC05

ATC

esomeprazole; systemic

1.8

118.8

3053

20591

N02AA05

ATC

oxycodone; systemic

2.3

118.3

1297

6282

F10.20

ICD-10 Finland

Alcohol dependence currently independent

6.0

116.9

341

593

P01AB01

ATC

metronidazole; oral, rectal

1.8

116.3

2809

18527

UJF32

NOMESCO Finland

Coloscopy

1.9

113.5

2034

12072

J01DB01

ATC

cefalexin; oral

1.8

111.9

6099

51450

P15

ICPC

Chronic alcohol abuse

4.7

111.3

398

874

A02BC01

ATC

omeprazole; systemic

1.9

110.1

2169

13296

C03CA01

ATC

furosemide; systemic

1.8

110.1

2356

14858

JLB28

NOMESCO Finland

Endoscopic internal drainage of pancreatic duct

229.2

109.9

113

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

16.8

109.9

179

109

6663

FHL

Cholecystectomy and cholangiography

131.9

109.3

117

N06AX11

ATC

mirtazapine; oral

1.8

109.2

2400

15261

N05CF01

ATC

zopiclone; oral

1.8

109.1

2543

16490

SPAT1262

SPAT

Handing over of treatment supplies

2.1

108.3

1549

8401

N05AH04

ATC

quetiapine; oral

2.2

106.8

1281

6439

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

105.4

2010

12143

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

6.3

103.2

287

469

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.0

102.7

1521

8345

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

37.3

102.6

132

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.2

102.3

1260

6397

D01

ICPC

Abdominal pain/cramps general

2.6

100.6

789

3187

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.5

100.5

886

3819

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

14.1

100.2

175

127

57409

ICD-8 Finland

Cholelithiasis, Unspecified

+∞

100.2

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

10.3

100.0

203

202

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.1

99.5

607

2093

N05BA01

ATC

diazepam; systemic, rectal

2.2

98.9

1139

5602

N03AX16

ATC

pregabalin; oral

1.9

96.7

1800

10727

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.1

95.0

1300

6879

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.7

94.4

447

1273

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

94.0

4423

34665

J01MA02

ATC

ciprofloxacin; systemic

1.7

92.7

2972

20948

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.5

91.3

760

3167

TPH07

NOMESCO Finland

Cathetrisation of artery

2.3

90.7

896

4086

F10.24

ICD-10 Finland

Alcohol depence active use

6.3

90.6

252

412

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.3

89.3

946

4460

JLD12

NOMESCO Finland

Endoscopic drainage of pancreatic pseudocyst

305.8

88.9

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.3

87.5

891

4120

A05AA02

ATC

ursodeoxycholic acid; oral

9.0

86.7

189

214

R11

ICD-10 Finland

Nausea and vomiting

2.7

86.6

631

2432

E13

ICD-10 Finland

Other specified diabetes mellitus

54.9

86.4

103

TJK00

NOMESCO Finland

Intraoperative cholangiography

182.0

86.4

K70.1

ICD-10 Finland

Alcoholic hepatitis

12.9

84.0

152

120

A02BA02

ATC

ranitidine; systemic

1.9

83.9

1558

9207

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

7.3

83.9

209

293

B01AB05

ATC

enoxaparin; parenteral

1.7

83.5

2225

14761

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.5

83.1

693

2885

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.0

83.1

1251

6843

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

10.4

82.9

167

164

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

214.7

82.5

TKC20

NOMESCO Finland

Catheterisation of bladder

2.5

82.4

687

2858

N05BA02

ATC

chlordiazepoxide; systemic

4.3

82.0

323

780

WX402

NOMESCO Finland

General anaesthesia

2.0

81.6

1218

6635

N05BA04

ATC

oxazepam; oral

1.8

80.9

1781

11123

A02BC03

ATC

lansoprazole; oral

1.7

80.6

2164

14356

JLC30

NOMESCO Finland

Pancreatoduodenectomy

42.1

79.9

100

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

7.0

79.6

204

298

WX002

NOMESCO Finland

Sedation and analgesia

1.8

78.5

1486

8817

K86.0

ICD-10 Finland

Alcohol-induced chronic pancreatitis

+∞

78.2

UJK12

NOMESCO Finland

Peroral cholangioscopy

119.8

77.0

JLB35

NOMESCO Finland

Transduodenal endoscopic extraction of foreign body from pancreatic duct

386.2

76.9

F10.09

ICD-10 Finland

Alcohol intoxication UNS

4.6

76.5

281

633

E13.8

ICD-10 Finland

Other specified diabetes mellitus, with unspecified complications

36.7

76.1

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.2

76.0

305

749

T89

ICPC

Diabetes insulin dependent

3.6

75.9

366

1056

N06AB04

ATC

citalopram; systemic

1.8

75.6

1572

9605

H02AB06

ATC

prednisolone; systemic

1.6

74.6

3362

25434

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.8

73.8

330

893

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

12.4

73.3

135

111

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

4.9

72.7

248

517

A10AE05

ATC

insulin detemir; parenteral

2.8

72.6

503

1875

A06AD11

ATC

lactulose; oral

1.9

72.6

1158

6445

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

10.2

71.4

145

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.3

71.2

386

1218

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

6.0

70.4

203

348

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

6.4

70.4

193

310

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

70.3

2015

13512

N05CD07

ATC

temazepam; oral

2.0

69.5

1041

5647

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

69.5

941

4905

R50.9

ICD-10 Finland

Fever, unspecified

2.0

69.5

1037

5620

57408

ICD-8 Finland

Cholelithiasis, Alia definita

+∞

68.8

UJD02

NOMESCO Finland

Gastroscopy

2.9

68.2

440

1566

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.9

67.6

452

1646

AA1AD

NOMESCO Finland

CT of head and brain

1.7

67.2

1766

11533

JAH00

NOMESCO Finland

Laparotomy

4.0

67.1

282

723

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

66.3

2143

14799

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

75.8

66.1

WX110

NOMESCO Finland

Local anesthesy

1.5

66.0

4702

39038

57401

ICD-8 Finland

Cholelithiasis, Cum cholecystitide chronica

+∞

65.7

JLC50

NOMESCO Finland

Atypical pancreatectomy

+∞

65.7

5770C

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA NONALCOHOLICA RECIDIVANS]

+∞

65.7

E13.7

ICD-10 Finland

Other specified diabetes mellitus, with multiple complications

46.9

64.6

K92.0

ICD-10 Finland

Haematemesis

3.9

64.6

283

753

WX892

NOMESCO Finland

Monitored bed care

2.3

64.5

638

2888

K30

ICD-10 Finland

Functional dyspepsia

2.2

64.5

728

3507

P16

ICPC

Acute alcohol abuse

4.9

64.4

218

451

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.1

63.9

377

1261

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

4.9

63.6

218

457

C07AB07

ATC

bisoprolol; oral

1.5

63.3

3451

26909

J01DA01

ATC

[U] cefalexin; systemic

1.5

63.3

4438

36547

K29.2

ICD-10 Finland

Alcoholic gastritis

17.0

61.6

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

60.7

1203

7178

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

310.0

60.4

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

60.3

3225

24946

JK3SB

NOMESCO Finland

Endoscopic retrorade cholangiography

158.7

60.0

R4110

NOMESCO Finland

Physiotherapy

1.6

59.8

1891

12917

57400

ICD-8 Finland

Cholelithiasis, Cum cholecystitide acuta

+∞

59.4

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.8

59.2

394

1430

N06AX16

ATC

venlafaxine; oral

1.9

59.0

897

4874

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.9

58.7

376

1331

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

58.6

1908

13117

A03FA01

ATC

metoclopramide; systemic, rectal

1.7

58.6

1386

8730

5770B

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA NONALCOHOLICA HAEMORRHAGICA]

+∞

58.4

K85.3

ICD-10 Finland

Drug-induced acute pancreatitis

+∞

58.4

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

5.3

58.3

186

361

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

57.9

786

4083

57700

ICD-8 Finland

Diseases of pancreas, Pancreatitis acuta haemorrhagica

+∞

57.3

A10BH01

ATC

sitagliptin; oral

2.1

57.2

735

3736

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

4.9

57.2

194

403

K80

ICD-10 Finland

Cholelithiasis

13.1

57.0

102

C08CA01

ATC

amlodipine; oral

1.5

55.4

2574

19199

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.0

54.8

822

4438

JK3BT

NOMESCO Finland

Catherisation of bile duct with X-ray guidance

33.0

54.8

R53

ICD-10 Finland

Malaise and fatigue

1.7

53.9

1384

8897

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.5

53.8

435

1767

ZX120

NOMESCO Finland

Intravenous

2.0

53.4

703

3605

M54.5

ICD-10 Finland

Low back pain

1.5

52.9

2108

15151

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

5.2

52.7

170

334

N05AB01

ATC

dixyrazine; systemic

5.2

52.6

169

331

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.2

52.3

284

897

6662

FHL

Cholecystectomy

39.2

52.2

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.8

52.2

352

1286

N03AX12

ATC

gabapentin; oral

1.8

52.1

1067

6406

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

4.2

52.1

208

509

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

51.8

1210

7558

D64.9

ICD-10 Finland

Anaemia, unspecified

1.9

51.2

772

4171

SPAT1254

SPAT

Administration of medicine

1.8

51.1

1039

6223

R06.0

ICD-10 Finland

Dyspnoea

1.6

50.9

1689

11601

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

50.8

3373

26944

A03DA02

ATC

pitofenone and analgesics; systemic

4.4

50.7

190

438

JN4BD

NOMESCO Finland

Extensive body CT

1.9

50.5

833

4648

JN4AD

NOMESCO Finland

Body CT examination

2.1

50.5

591

2881

SPAT1263

SPAT

Sampling

1.5

50.5

2811

21670

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

6.4

50.2

136

216

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.6

50.2

377

1471

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

50.1

1192

7482

L04AX01

ATC

azathioprine; systemic

2.7

50.0

357

1351

5740A

ICD-9 Finland

Cholelithiasis, Calculus of gallbladder with acute cholecystitis[CHOLECYSTOLITHIASIS CUM CHOLECYSTITIDE AC,SINE OBST]

+∞

50.0

5770E

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA ALCOHOLICAHAEMORRHAGICA]

+∞

50.0

JLB42

NOMESCO Finland

Transduodenal endoscopic dilatation of pancreatic duct

+∞

50.0

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

7.3

49.6

122

169

N06AX21

ATC

duloxetine; oral

2.0

49.5

714

3788

TK800

NOMESCO Finland

Hemodialysis

3.7

49.3

223

610

Z72.1

ICD-10 Finland

Alcohol use

4.9

49.2

165

339

57710

ICD-8 Finland

Diseases of pancreas, Pancreatitis chronica recidivans

+∞

49.0

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

16.6

48.9

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

5.9

48.7

141

244

JLC10

NOMESCO Finland

Distal pancreatectomy

22.4

48.7

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

5.4

48.4

149

278

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

48.3

2079

15142

5772A

ICD-9 Finland

Diseases of pancreas, Cyst and pseudocyst of pancreas[CYSTA ET PSEUDOCYSTA PANCREATIS]

+∞

48.0

C07AA05

ATC

propranolol; systemic

1.7

47.7

1220

7808

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

7.3

47.6

117

162

D98

ICPC

Cholecystitis/cholelithiasis

30.7

45.7

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.3

45.5

435

1929

A41.9

ICD-10 Finland

Sepsis, unspecified

2.8

45.3

307

1124

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

45.1

974

5925

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.3

45.0

430

1908

K92.1

ICD-10 Finland

Melaena

2.3

45.0

427

1888

S18

ICPC

Laceration/cut

1.4

44.8

2826

22174

N05AA02

ATC

levomepromazine; systemic

2.6

44.8

350

1395

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

44.2

874

5169

M04AA01

ATC

allopurinol; systemic

1.7

43.8

1008

6243

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

3.0

43.8

259

870

A10BB12

ATC

glimepiride; oral

2.0

43.5

563

2858

XF600

NOMESCO Finland

Bloodpressure measurement

2.2

43.3

469

2206

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

43.2

887

5308

JN4CD

NOMESCO Finland

Very extensive body CT

2.7

43.2

318

1224

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.9

43.1

272

953

M79.6

ICD-10 Finland

Pain in limb

1.5

42.6

2234

16868

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

5.3

42.6

133

253

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

4.4

42.3

159

368

JAH01

NOMESCO Finland

Laparoscopy

2.8

41.8

284

1044

J01FF01

ATC

clindamycin; systemic

1.5

41.8

1819

13205

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.7

41.6

299

1136

WX872

NOMESCO Finland

Intensive care

2.3

41.6

422

1922

UJF30

NOMESCO Finland

Ileoscopy through colon

1.9

41.5

641

3482

E87.6

ICD-10 Finland

Hypokalaemia

3.0

41.2

249

848

A07EC02

ATC

mesalazine; oral, rectal

2.3

40.7

412

1878

57500

ICD-8 Finland

Cholecystitis and cholangitis, without mention of calculus, Cholecystitis acuta

+∞

40.6

C10AC01

ATC

colestyramine; oral

3.5

40.4

199

585

A10BH05

ATC

linagliptin; oral

2.4

40.4

366

1581

N06AB10

ATC

escitalopram; oral

1.6

40.2

1194

7920

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

31.4

40.0

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.1

39.8

508

2561

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.1

39.8

481

2371

N05BA12

ATC

alprazolam; oral

1.9

39.7

675

3794

57701

ICD-8 Finland

Diseases of pancreas, Pancreatitis acuta cum abscessu

+∞

39.6

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

39.5

2569

20139

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

39.5

1152

7599

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.9

39.3

245

852

H02AB07

ATC

prednisone; oral

1.7

39.3

981

6208

K29.7

ICD-10 Finland

Gastritis, unspecified

2.7

39.3

273

1017

WX882

NOMESCO Finland

High dependency care

3.0

39.2

239

820

C03DA01

ATC

spironolactone; oral

1.8

38.9

753

4413

D13.6

ICD-10 Finland

Benign neoplasm: Pancreas

10.4

38.8

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

4.9

38.5

130

270

V03AA01

ATC

3.4

38.4

192

571

SPAT1265

SPAT

Breathalyser

5.3

38.4

121

233

J01MA14

ATC

moxifloxacin; systemic

1.9

38.0

624

3461

1280

FHL

Endoscopic retrograde cholangiography and pancreaticography

84.5

37.8

JLT00

NOMESCO Finland

Extracorporeal shock wave lithotripsy of pancreatic duct

+∞

37.5

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.6

37.3

290

1153

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

3.7

37.1

165

447

Z71.4

ICD-10 Finland

Alcohol abuse counselling and surveillance

7.5

37.1

120

N06AA09

ATC

amitriptyline; systemic

1.8

37.0

661

3771

K81.1

ICD-10 Finland

Chronic cholecystitis

369.1

37.0

K50.8

ICD-10 Finland

Other Crohn disease

4.4

37.0

139

323

5353A

ICD-9 Finland

Gastritis and duodenitis, Alcoholic gastritis

23.2

37.0

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

3.1

36.9

211

691

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

6.0

36.9

104

175

WX004

NOMESCO Finland

Patient-controlled sedation

10.7

36.9

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

36.9

1226

8342

WVA20

NOMESCO Finland

Medicine administration

3.4

36.7

187

565

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.7

36.6

257

964

JK3NB

NOMESCO Finland

Percutaneous transhepatic cholangiography

32.2

36.6

N06AB06

ATC

sertraline; oral

1.8

36.4

654

3736

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

36.4

515

2702

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.8

36.2

681

3951

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.9

36.2

226

787

D06

ICPC

Abdominal pain localized other

2.0

36.1

471

2397

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.1

36.0

442

2192

JKB20

NOMESCO Finland

Intraoperative cholangioscopy

358.9

36.0

E13.4

ICD-10 Finland

Other specified diabetes mellitus, with neurological complications

80.5

35.8

B03BA03

ATC

hydroxocobalamin; parenteral

2.1

35.7

416

2019

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

35.6

1960

14838

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

6.1

35.5

165

5771C

ICD-9 Finland

Diseases of pancreas, Chronic pancreatitis[PANCREATITIS CHRONICA ALCOHOLICA RECIDIVANS]

+∞

35.4

130

Kela drug reimbursment

Malignant tumour

1.9

35.4

596

3333

A46

ICD-10 Finland

Erysipelas

1.6

35.2

987

6430

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.5

34.8

294

1223

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

34.8

679

3987

C09AA05

ATC

ramipril; oral

1.4

34.8

1753

13033

JL5CM

NOMESCO Finland

Bile and pancreas ducts extensive MRI examination with 3 Tesla magnet

180.8

34.8

EBA00

NOMESCO Finland

Extraction of tooth

1.4

34.5

2094

16117

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

34.5

2561

20426

A10BK03

ATC

empagliflozin; oral

2.0

34.4

497

2629

K50.9

ICD-10 Finland

Crohn disease, unspecified

4.2

34.3

133

319

N06AB03

ATC

fluoxetine; oral

1.7

34.2

783

4824

N07BA03

ATC

varenicline; oral

2.2

34.1

361

1679

JMA10

NOMESCO Finland

Transabdominal total splenectomy

8.0

34.1

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

33.9

1614

11857

JKB00

NOMESCO Finland

Incision of bile duct

175.7

33.7

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.3

33.6

321

1424

K51.5

ICD-10 Finland

Left sided colitis

2.9

33.5

216

769

A10AE06

ATC

insulin degludec; parenteral

2.8

33.3

219

789

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

33.3

717

4338

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

33.2

2061

15905

K70.4

ICD-10 Finland

Alcoholic hepatic failure

8.4

33.2

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.7

33.2

767

4735

6664

FHL

Cholecystectomy and choledocotomy

328.5

32.9

205

Kela drug reimbursment

Chronic hypertension

1.4

32.9

1960

15012

B01AB10

ATC

tinzaparin; parenteral

2.0

32.6

451

2347

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

32.4

1480

10765

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

32.4

2360

18708

JLD22

NOMESCO Finland

Endoscopic drainage of pancreatic pseudocyst to jejunum

+∞

32.3

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.8

32.3

218

799

K70.0

ICD-10 Finland

Alcoholic fatty liver

5.9

32.3

158

S06.0

ICD-10 Finland

Concussion

1.7

32.1

661

3943

WX290

NOMESCO Finland

Other blockade of nerve

1.4

32.0

2624

21199

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

32.0

521

2880

E66.01

ICD-10 Finland

Obesity due to excess calories

2.0

31.9

431

2224

J01FA06

ATC

roxithromycin; oral

1.4

31.8

2575

20757

A28

ICPC

Limited function/disability NOS

1.6

31.8

975

6488

JLB12

NOMESCO Finland

Transduodenal endoscopic incision of pancreatic duct orifice

113.8

31.7

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.3

31.6

297

1306

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.0

31.6

433

2246

N05CF02

ATC

zolpidem; oral

1.5

31.6

1071

7299

R4190

NOMESCO Finland

Nutritional therapy

2.7

31.5

226

860

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

5.2

31.4

192

E0000UV

ATC

1.4

31.1

2415

19315

L03

ICPC

Low back symptom/complaint

1.5

30.9

1388

10054

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.3

30.9

305

1374

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

30.9

965

6445

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

30.8

1345

9680

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

4.0

30.8

126

318

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

30.8

613

3614

N06AA12

ATC

doxepin; systemic

2.1

30.5

381

1903

A07EA06

ATC

budesonide; oral, local oral

2.5

30.4

243

982

5771D

ICD-9 Finland

Diseases of pancreas, Chronic pancreatitis[PANCREATITIS CHRONICA ALCOHOLICA NUD]

+∞

30.2

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.9

30.2

467

2531

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

30.0

2473

19943

R03AC02

ATC

salbutamol; inhalant

1.3

30.0

3305

27860

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.5

29.9

247

1016

E86

ICD-10 Finland

Volume depletion

2.8

29.9

194

694

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

29.9

488

2699

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.2

29.8

313

1452

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.1

29.6

346

1682

K59.09

ICD-10 Finland

Constipation, unspecified

2.0

29.5

398

2051

N03AX09

ATC

lamotrigine; oral

2.3

29.4

273

1192

E66.8

ICD-10 Finland

Other obesity

2.3

29.3

292

1320

57719

ICD-8 Finland

Diseases of pancreas, Pancreatitis chronica NUD

+∞

29.2

5741A

ICD-9 Finland

Cholelithiasis, Calculus of gallbladder with other cholecystitis[CHOLECYSTOLITHIASIS CUM CHOLECYSTITIDE CHR,SINE OBS]

+∞

29.2

57403

ICD-8 Finland

Cholelithiasis, Choledocholithiasis

+∞

29.2

SPAT1260

SPAT

Consultation of another employee

1.5

29.2

1105

7709

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

28.9

450

2446

A02BA04

ATC

nizatidine; systemic

1.8

28.9

540

3122

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

28.8

487

2724

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

7.8

28.8

XCK10

NOMESCO Finland

Photography of fundus of eye

1.7

28.8

682

4232

JN1AD

NOMESCO Finland

CT examination of upper part of abdomen

8.5

28.6

N06AX03

ATC

mianserin; oral

2.1

28.3

329

1594

C10AB05

ATC

fenofibrate; oral

3.1

28.3

157

507

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.4

28.3

244

1029

R51.80

ICD-10 Finland

Headache

1.6

28.0

794

5172

N03AF01

ATC

carbamazepine; oral, rectal

2.0

27.9

366

1862

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

4.2

27.9

109

265

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

4.4

27.8

102

233

K50.0

ICD-10 Finland

Crohn disease of small intestine

3.7

27.8

123

334

K81.8

ICD-10 Finland

Other cholecystitis

282.5

27.8

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.0

27.7

354

1784

B01AA03

ATC

warfarin; systemic

1.4

27.7

1402

10367

L28

ICPC

Limited function/disability (L)

1.5

27.6

973

6676

A01

ICPC

Pain general/multiple sites

1.8

27.6

467

2614

SPAT1255

SPAT

Intravenous administration of medicine

1.9

27.6

438

2397

I81

ICD-10 Finland

Portal vein thrombosis

9.1

27.5

C09AA02

ATC

enalapril; systemic

1.4

27.3

1357

9997

J01CA04

ATC

amoxicillin; systemic

1.3

27.3

5394

49076

M03BX02

ATC

tizanidine; oral

1.3

27.2

3937

34299

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.3

27.2

250

1089

D10

ICPC

Vomiting

2.2

27.1

282

1303

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.2

27.1

292

1372

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

26.9

600

3659

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

8.7

26.8

J02AC01

ATC

fluconazole; systemic

1.3

26.8

2107

16794

I50.9

ICD-10 Finland

Heart failure, unspecified

1.5

26.8

912

6201

E13.3

ICD-10 Finland

Other specified diabetes mellitus, with ophthalmic complications

75.4

26.8

B81

ICPC

Anaemia vit B12/folate deficiency

2.3

26.6

257

1144

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

26.6

1661

12747

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

26.5

502

2913

WZC30

NOMESCO Finland

Teaching

1.6

26.4

833

5565

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

8.9

26.3

N05BE01

ATC

buspirone; oral

2.5

26.3

217

893

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.8

26.3

170

609

K02.1

ICD-10 Finland

Caries of dentine

1.3

26.3

3519

30276

S97

ICPC

Chronic ulcer skin

2.0

26.3

366

1909

S22.3

ICD-10 Finland

Fracture of rib

1.8

26.2

457

2580

K56.7

ICD-10 Finland

Ileus, unspecified

3.2

26.2

140

441

E87.2

ICD-10 Finland

Acidosis

6.3

26.1

112

D11

ICPC

Diarrhoea

1.7

26.0

577

3510

SPAT1301

SPAT

No procedures

1.3

26.0

1990

15784

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.9

25.8

160

556

K29.1

ICD-10 Finland

Other acute gastritis

3.5

25.7

123

356

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

25.6

459

2617

K76.9

ICD-10 Finland

Liver disease, unspecified

3.9

25.6

106

272

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.7

25.5

173

638

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.0

25.4

341

1755

Z71.8

ICD-10 Finland

Other specified counselling

1.4

25.4

1358

10129

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.5

25.4

121

350

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.0

25.3

335

1712

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

25.3

533

3196

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

7.1

25.2

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

25.2

648

4111

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

25.2

1053

7482

K65.0

ICD-10 Finland

Acute peritonitis

4.0

25.1

103

262

W19

ICD-10 Finland

Unspecified fall

1.7

25.1

602

3749

5771A

ICD-9 Finland

Diseases of pancreas, Chronic pancreatitis[PANCREATITIS CHRONICA NONALCOHOLICA RECIDIVANS]

+∞

25.0

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.4

25.0

123

365

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

24.8

877

6010

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2.2

24.5

246

1117

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

24.5

696

4527

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

24.4

794

5339

SPAT1227

SPAT

Substance abuse rehabilitation

5.6

24.1

128

J01AA02

ATC

doxycycline; systemic

1.3

24.1

5361

49038

H02AB04

ATC

methylprednisolone; systemic

1.5

24.1

882

6086

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.2

24.1

248

1140

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

24.1

1082

7798

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

24.0

1740

13644

E13.1

ICD-10 Finland

Other specified diabetes mellitus, with ketoacidosis

29.2

24.0

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.4

24.0

117

345

57600

ICD-8 Finland

Other diseases of gallbladder and biliary, Cholesterosis vesicae felleae

+∞

24.0

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

23.9

1678

13098

WX704

NOMESCO Finland

Intubation

1.8

23.8

425

2420

E13.2

ICD-10 Finland

Other specified diabetes mellitus, with renal complications

67.6

23.8

A03FA02

ATC

cisapride; oral, rectal

1.7

23.8

469

2755

JAH33

NOMESCO Finland

Opening of laparostomy

11.0

23.8

L17

ICPC

Foot/toe symptom/complaint

1.4

23.7

1478

11304

E87.5

ICD-10 Finland

Hyperkalaemia

3.1

23.7

130

418

XX9TE

NOMESCO Finland

Compementary ultrasound examination

5.4

23.7

135

R60.0

ICD-10 Finland

Localized oedema

1.6

23.7

663

4296

C07AB02

ATC

metoprolol; systemic

1.4

23.6

1362

10282

S01.0

ICD-10 Finland

Open wound of scalp

1.7

23.6

520

3156

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

23.4

1142

8360

A11CC03

ATC

alfacalcidol; systemic

2.7

23.3

168

642

R03BB04

ATC

tiotropium bromide; inhalant

1.6

23.3

675

4411

JDE00

NOMESCO Finland

Gastrojejunostomy

12.1

23.2

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.4

23.2

192

795

WW500

NOMESCO Finland

Blood transfusion

2.1

23.1

256

1216

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

5.5

23.0

124

57609

ICD-8 Finland

Other diseases of gallbladder and biliary, Alii definiti sive NUD

+∞

22.9

57792

ICD-8 Finland

Diseases of pancreas, Cysta pancreatis

+∞

22.9

F10.3

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state

6.6

22.9

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

22.7

864

6008

N17.8

ICD-10 Finland

Other acute renal failure

3.7

22.7

100

272

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

22.7

1524

11794

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

4.0

22.6

233

E89.1

ICD-10 Finland

Postprocedural hypoinsulinaemia

120.3

22.6

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

2.3

22.6

217

968

P01

ICPC

Feeling anxious/nervous/tense

1.7

22.5

440

2577

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.8

22.5

150

546

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

22.5

918

6480

A41.8

ICD-10 Finland

Other specified sepsis

3.1

22.5

126

412

C01DA14

ATC

isosorbide mononitrate; oral

1.4

22.2

1041

7560

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.7

22.0

154

581

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

22.0

939

6692

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.7

21.9

459

2748

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.5

21.9

177

723

JLD10

NOMESCO Finland

Anastomosis of pancreatic pseudocyst to stomach

+∞

21.9

JK3PB

NOMESCO Finland

Peroperative cholangiography

+∞

21.9

5745A

ICD-9 Finland

Cholelithiasis, Calculus of bile duct without mention of cholecystitis[CHOLEDOCHOLITHIASIS SINE CHOLECYSTITIDE,SINE OBSTR]

+∞

21.9

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

21.8

594

3818

K59.1

ICD-10 Finland

Functional diarrhoea

2.0

21.8

287

1466

K29.8

ICD-10 Finland

Duodenitis

4.3

21.8

194

N05AF03

ATC

chlorprothixene; systemic

2.4

21.7

192

822

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

21.7

617

4015

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

21.7

852

5966

JLD00

NOMESCO Finland

Pancreaticojejunostomy

220.5

21.6

N19

ICD-10 Finland

Unspecified kidney failure

2.2

21.6

233

1096

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

3.4

21.6

106

315

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

21.6

1346

10279

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.8

21.6

140

502

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

7.4

21.5

N06AB05

ATC

paroxetine; oral

1.8

21.5

360

2006

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.3

21.5

111

343

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

2.7

21.5

149

559

A03

ICPC

Fever

1.5

21.4

807

5600

E14.8

ICD-10 Finland

Unspecified diabetes mellitus, with unspecified complications

7.8

21.4

E14.1

ICD-10 Finland

Unspecified diabetes mellitus, with ketoacidosis

12.3

21.2

SPAT1104

SPAT

Monitoring of emergency patient

1.8

21.2

409

2385

53502

ICD-8 Finland

Gastritis and duodenitis, Gastritis acuta NUD

5.2

21.2

128

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

4.2

20.9

192

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

20.9

1522

11911

30320

ICD-8 Finland

Alcoholism, Alcoholic addiction

3.9

20.9

221

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.8

20.8

373

2125

R07.3

ICD-10 Finland

Other chest pain

1.6

20.8

560

3591

JN1CM

NOMESCO Finland

Upper part of abdomen extensive MRI examination with 3 Tesla magnet

14.1

20.8

A02BA03

ATC

famotidine; systemic

2.0

20.7

268

1360

JL5BM

NOMESCO Finland

Bile and pancreas ducts MRI examination with 3 Tesla magnet

77.0

20.7

R02

ICPC

Shortness of breath/dyspnoea

1.5

20.6

704

4783

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.5

20.5

685

4626

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

20.5

961

6968

E78.11

ICD-10 Finland

Other hypertriglyceridemia

5.2

20.5

125

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.7

20.4

146

557

N06AX05

ATC

trazodone; oral

2.5

20.4

158

632

C10AA01

ATC

simvastatin; oral

1.3

20.4

2929

25137

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

4.1

20.2

194

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

20.2

628

4172

N18.8

ICD-10 Finland

Other chronic renal failure

2.3

20.2

193

861

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.6

20.2

145

556

WX730

NOMESCO Finland

Conventional respirator

2.8

20.1

129

463

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

20.0

1305

10024

A04

ICPC

Weakness/tiredness general

1.5

20.0

706

4826

309

Kela drug reimbursment

Nalmefene and naltrexone

5.9

19.9

K50.1

ICD-10 Finland

Crohn disease of large intestine

3.4

19.8

283

JLW96

NOMESCO Finland

Other operation on pancreas

+∞

19.8

JK1AT

NOMESCO Finland

Cathetrisation of bile cyst with radiological guidance

+∞

19.8

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

3.8

19.7

228

N30.0

ICD-10 Finland

Acute cystitis

1.5

19.6

704

4831

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

19.6

613

4078

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

19.5

4479

40521

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

3.3

19.4

293

GBB00

NOMESCO Finland

Tracheostomy

3.2

19.4

104

331

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.5

19.4

157

641

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

19.3

1334

10338

K08.3

ICD-10 Finland

Retained dental root

1.7

19.3

442

2715

L86

ICPC

Back syndrome with radiating pain

1.8

19.3

315

1742

M10.9

ICD-10 Finland

Gout, unspecified

1.7

19.2

437

2678

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

4.6

19.1

144

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

19.1

3389

29741

F05.9

ICD-10 Finland

Delirium, unspecified

2.6

19.1

145

572

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

19.1

558

3649

N05AH03

ATC

olanzapine; systemic

1.8

19.1

334

1891

F10.22

ICD-10 Finland

Alcohol dependence is currently on clinically controlled discontinuation medication

7.4

19.1

TK810

NOMESCO Finland

Hemofiltration

4.5

19.0

149

Z53.8

ICD-10 Finland

Procedure not carried out for other reasons

7.6

19.0

SPAT1240

SPAT

Therapeutic discussion

1.6

19.0

522

3366

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

7.1

19.0

E66.00

ICD-10 Finland

Metabolic syndrome

1.8

19.0

318

1775

D07AA02

ATC

hydrocortisone; topical

1.5

18.9

755

5295

E14

ICD-10 Finland

Unspecified diabetes mellitus

7.3

18.9

JK3FT

NOMESCO Finland

Exchange of bile duct catheter with radiological guidance

34.4

18.9

R42

ICD-10 Finland

Dizziness and giddiness

1.4

18.8

1259

9703

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

18.8

364

2127

JAD10

NOMESCO Finland

Repair of incisional hernia

4.8

18.8

129

S10

ICPC

Boil/carbuncle

1.8

18.8

326

1842

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

18.8

412

2501

57798

ICD-8 Finland

Diseases of pancreas, Alii definiti

+∞

18.8

W10

ICD-10 Finland

Fall on and from stairs and steps

1.8

18.6

302

1666

M01AX17

ATC

nimesulide; oral

1.3

18.6

1498

11870

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

18.6

701

4860

P18

ICPC

Medication abuse

5.4

18.6

105

B01AB04

ATC

dalteparin; parenteral

1.9

18.6

294

1607

M01AB05

ATC

diclofenac; systemic, rectal

1.2

18.6

4394

39768

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.1

18.6

211

1016

JK3MB

NOMESCO Finland

Postoperative cholangiography

190.4

18.5

E13.0

ICD-10 Finland

Other specified diabetes mellitus, with coma

190.4

18.5

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

5.1

18.5

114

A12BA01

ATC

potassium chloride; oral

1.9

18.5

289

1573

RD210

NOMESCO Finland

2.9

18.4

114

400

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.9

18.4

256

1337

NF1AA

NOMESCO Finland

Hip X-ray examination

1.6

18.3

516

3343

SPAT1310

SPAT

Counselling related to known health issue

1.3

18.3

1889

15498

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.2

18.3

307

R18

ICD-10 Finland

Ascites

2.7

18.3

122

449

J20

ICD-10 Finland

Acute bronchitis

1.6

18.2

517

3358

JKD20

NOMESCO Finland

Anastomosis of bile duct to jejunum

44.1

18.2

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

7.9

18.2

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

4.3

18.2

161

A07AA02

ATC

nystatin; oral

1.7

18.1

361

2126

JDA08

NOMESCO Finland

Endoscopic removal of foreign body from stomach or pylorus

19.3

18.1

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.4

18.0

267

K51.8

ICD-10 Finland

Other ulcerative colitis

3.1

18.0

316

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

18.0

2889

25014

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.3

17.9

169

749

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.2

17.9

290

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

17.8

176

796

K25.0

ICD-10 Finland

Gastric ulcer, Acute with haemorrhage

3.1

17.8

313

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.5

17.8

137

545

127

Kela drug reimbursment

Transplant complication

2.9

17.8

108

373

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

17.7

368

2197

5750A

ICD-9 Finland

Other disorders of gallbladder, Acute cholecystitis

+∞

17.7

Z94.4

ICD-10 Finland

Liver transplant status

7.9

17.7

N03AG01

ATC

valproic acid; systemic, rectal

1.7

17.7

348

2044

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.7

17.7

394

2401

UJK42

NOMESCO Finland

Peroral pancreaticoscopy

95.2

17.5

E66.9

ICD-10 Finland

Obesity, unspecified

2.2

17.5

179

822

UKC02

NOMESCO Finland

Cystoscopy

1.4

17.5

1051

7949

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

17.5

379

2291

PD1BD

NOMESCO Finland

Extensive CT of abdominal aorta and branches

3.4

17.4

253

30310

ICD-8 Finland

Alcoholism, Habitual excessive drinking

3.8

17.4

192

E16.19

ICD-10 Finland

Other specified hypoglycaemia

6.5

17.4

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.4

17.4

142

587

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.4

17.3

144

598

UJF02

NOMESCO Finland

Peroral enteroscopy

4.7

17.3

123

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

17.3

769

5511

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.3

17.3

1422

11291

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

3.2

17.3

282

JFB00

NOMESCO Finland

Partial resection of small intestine

2.9

17.2

107

377

M25.5

ICD-10 Finland

Pain in joint

1.3

17.2

1575

12695

SPAT1247

SPAT

Outpatient detoxication and monitoring

4.8

17.2

120

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

17.1

387

2366

M48.0

ICD-10 Finland

Spinal stenosis

1.5

17.1

721

5113

F10

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol

9.2

17.1

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.7

17.1

116

433

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.6

17.1

221

WX306

NOMESCO Finland

Lumbar epidural anesthesy

1.8

17.0

290

1631

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

16.9

979

7355

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.9

16.9

100

342

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

16.9

449

2869

L04AA06

ATC

mycophenolic acid; systemic

2.7

16.8

117

442

G44.2

ICD-10 Finland

Tension-type headache

1.5

16.8

654

4563

SPAT1211

SPAT

Application of soft bandage

1.6

16.8

508

3351

RS220

NOMESCO Finland

3.1

16.7

306

6727

FHL

Cystoenterostomy (includes pseudocyst)

+∞

16.7

E16.89

ICD-10 Finland

Other specified disorders of pancreatic internal secretion

+∞

16.7

JKB21

NOMESCO Finland

Laparoscopic cholangioscopy

+∞

16.7

JLB96

NOMESCO Finland

Other incision, drainage or dilatation of pancreas

+∞

16.7

JKB11

NOMESCO Finland

Laparoscopic extraction of calculus from bile duct through cystic duct

+∞

16.7

K83.3

ICD-10 Finland

Fistula of bile duct

+∞

16.7

5742B

ICD-9 Finland

Cholelithiasis, Calculus of gallbladder without mention of cholecystitis[CHOLECYSTOLITHIASIS SINE CHOLECYSTITIDE,CUM OBSTR]

+∞

16.7

M01AB55

ATC

diclofenac, combinations; oral

1.6

16.7

404

2521

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

16.7

4369

39747

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.7

16.6

328

1932

WX722

NOMESCO Finland

PEEP

1.8

16.6

299

1711

P76

ICPC

Depressive disorder

1.8

16.6

299

1712

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(4062490)

460

563

8.57

307.65

1.6

1.3

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6134

34368

3.67

307.65

12.0

5.8

umol/l

13.3

11.4

13.00

5927

32520

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2012

5557

4.41

307.65

6.7

1.9

u/l

175.4

33.5

3.22

1814

4738

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

5016

19765

4.64

307.65

6.2

2.2

u/l

118.7

56.3

38.89

4768

18135

(3023368) Bacteria identified in Blood by Culture

3850

19052

2.83

307.65

6.3

4.2

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

4855

29451

2.47

307.65

8.3

4.6

g/l

33.5

35.4

82.89

4589

27163

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1866

5844

3.79

307.65

3.6

2.0

g/l

0.2

10.09

1779

5365

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2437

6672

4.69

307.65

5.3

2.3

umol/l

10.3

8.0

4.34

2193

5752

(3027135) IgG subclass 1 [Mass/volume] in Serum

459

558

8.63

307.65

1.6

1.3

g/l

6.1

6.9

3.03

212

410

(3032080) INR in Blood by Coagulation assay

4731

28475

2.45

307.65

11.7

9.2

inr

1.2

1.3

6.33

1397

7919

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4015

21084

2.68

307.65

5.4

3.1

u/l

47.9

34.0

4.81

3827

19876

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1211

1467

9.43

307.65

1.7

1.3

ug/g

214.7

299.3

18.10

737

849

(3024980) IgG subclass 4 [Mass/volume] in Serum

940

829

12.59

307.65

1.9

1.4

g/l

0.7

0.8

1.67

608

647

(3024139) IgG subclass 3 [Mass/volume] in Serum

459

558

8.63

307.65

1.6

1.3

g/l

0.4

0.04

210

412

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

928

2064

4.91

307.65

4.0

3.1

u/ml

677.0

1313.0

0.52

821

1772

(3028192) IgG subclass 2 [Mass/volume] in Serum

459

559

8.61

307.65

1.6

1.3

g/l

2.9

0.14

210

413

(3013826) Glucose [Moles/volume] in Serum or Plasma

5884

40611

2.39

303.54

8.3

4.7

mmol/l

7.4

6.8

58.89

5674

38026

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

590

1125

5.55

294.94

3.7

3.2

u/ml

844.2

862.3

0.01

550

1032

(3033658) Prothrombin time (PT) actual/Normal

3170

17137

2.34

289.35

7.9

3.7

85.4

88.2

7.85

3085

16701

(3017315) Amylase [Enzymatic activity/volume] in Urine

303

279

11.22

284.60

1.6

1.1

u/l

948.2

236.0

3.42

259

263

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6947

52343

2.63

284.22

14.8

7.1

u/l

95.1

76.6

84.35

6730

49090

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5141

34117

2.24

282.08

10.0

6.8

mmol/l

1.2

20.36

4387

28699

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4770

30995

2.19

272.11

9.2

6.1

mmol/l

1.2

19.61

4481

27965

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1633

6720

2.76

264.38

4.1

ug/l

9.4

22.2

3.18

1353

5491

(3014576) Chloride [Moles/volume] in Serum or Plasma

1942

8733

2.58

262.87

11.3

7.2

mmol/l

103.7

104.5

8.87

1905

8541

(3023183) Ammonium ion [Moles/volume] in Plasma

601

1377

4.61

241.66

3.7

2.6

umol/l

37.2

34.3

1.38

521

1162

(3044640) Blood type and Crossmatch panel - Blood

3522

21070

2.13

239.42

3.7

2.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1243

4700

2.92

234.06

2.6

2.7

g/l

10.6

0.08

1014

4325

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1903

8944

2.44

231.05

7.6

6.0

mmol/l

1.0

0.46

1796

8283

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1203

4702

2.81

211.73

1.8

1.6

—

(3018418) pH of Serum or Plasma

3308

20025

2.05

211.20

5.5

4.1

7.4

0.11

717

3779

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2157

11133

2.25

208.07

4.4

3.4

mmol/l

0.8

21.96

2042

10370

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

319

474

6.95

204.43

1.7

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4557

31244

1.96

200.39

5.4

4.0

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1449

6382

2.52

199.85

9.4

7.3

mmol/l

10.0

10.3

0.64

1384

6051

(3002582) Erythrocytes [#/volume] in Urine

3376

20911

2.00

199.26

4.0

3.3

e6/l

38.4

103.2

5.58

2756

16040

(3031040) Bacteria [#/volume] in Urine by Automated count

5829

43890

2.00

190.06

5.7

4.3

e6/l

680.1

1933.8

2.21

620

(3014111) Lactate [Moles/volume] in Serum or Plasma

1394

6194

2.49

187.79

9.8

7.2

mmol/l

1.5

1.4

2.38

1341

5919

(3013650) Neutrophils [#/volume] in Blood by Automated count

5304

38879

1.93

184.61

11.5

9.0

e9/l

4.8

4.1

52.52

4714

33781

(3000850) Epithelial cells [#/volume] in Urine

2535

14491

2.06

184.33

3.2

2.6

e6/l

5.9

4.6

5.28

2278

12645

(3030467) Casts [#/volume] in Urine by Automated count

3112

19173

1.97

182.71

4.0

3.2

e6/l

0.5

0.02

2492

14401

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2740

16173

2.01

181.76

3.5

2.4

—

(3026782) Osmolality of Urine

2389

13432

2.07

181.22

3.3

2.8

mosm/kgh2o

525.5

560.2

10.88

2109

11386

(3018095) Leukocytes [#/volume] in Urine

3676

24030

1.92

180.21

4.6

3.7

e6/l

73.8

95.2

0.97

2873

17239

(3042936) Bacteria identified in Isolate by Culture

1877

9664

2.20

178.75

2.7

2.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

561

1564

3.77

172.15

1.5

1.2

titre

69.8

154.8

1.31

141

(36304419) Bacteria [Presence] in Urine

2997

18564

1.94

170.53

3.9

3.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

314

572

5.66

163.97

1.4

1.3

nmol/l

1.1

1.5

7.91

285

511

(3034770) Mitochondria Ab [Titer] in Serum

544

1542

3.70

162.77

1.4

1.1

titre

881.8

953.1

0.05

(3000991) Gas panel - Venous blood

1287

5890

2.39

160.64

12.3

8.6

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2028

11209

2.06

157.99

2.1

1.8

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5756

44474

1.87

157.33

6.3

2.9

u/l

96.9

47.6

72.32

5428

41164

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3874

26647

1.82

154.19

4.9

3.6

ng/l

47.8

79.3

0.79

2952

18856

(3012544) pH of Venous blood

1399

6794

2.26

151.38

6.0

3.8

7.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1358

6536

2.28

150.04

6.0

3.8

kpa

5.8

1.58

1317

6322

(3002032) Base excess in Venous blood by calculation

1353

6519

2.27

149.02

6.0

3.8

mmol/l

1.5

1.9

2.80

1116

5246

(3009508) Creatinine [Moles/volume] in Urine

3316

21950

1.83

148.14

3.7

3.2

mmol/l

7.2

7.9

15.43

2756

18381

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

465

1276

3.79

145.65

2.4

1.7

nmol/l

0.7

0.8

4.18

383

1066

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2716

17060

1.86

142.55

2.6

2.2

mg/l

3.0

0.70

2347

14412

(3020682) Albumin/Creatinine [Ratio] in Urine

3297

22008

1.80

141.57

4.6

4.0

mg/mmol

16.0

9.3

6.25

2194

14181

(3012516) Albumin [Mass/volume] in Urine

3152

20916

1.80

136.91

3.7

3.2

mg/l

430.3

395.6

0.16

2143

13508

(3021162) Amylase [Enzymatic activity/volume] in Specimen

110

17.39

134.25

3.6

2.1

u/l

3452.9

828.8

1.30

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1538

8124

2.09

132.90

2.6

1.8

1.7

1.5

16.86

1315

7098

(3022948) Iron [Moles/volume] in Serum or Plasma

1894

10833

1.96

130.65

3.1

2.5

umol/l

11.9

13.0

8.76

1759

10008

(3026008) Bacteria identified in Urine by Culture

2911

19101

1.79

129.71

3.5

3.1

—

(42870588) Differential panel, method unspecified - Blood

3378

23226

1.74

127.29

7.3

5.9

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1684

9345

1.99

126.30

3.1

2.6

22.2

22.8

0.97

1456

7925

(3019069) Monocytes/100 leukocytes in Blood

4317

31814

1.71

125.91

7.9

6.3

8.7

8.8

2.46

4081

29666

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

811

3337

2.58

125.85

6.4

4.2

mmol/l

23.9

24.1

0.68

733

2992

(3006504) Eosinophils/100 leukocytes in Blood

4296

31640

1.71

125.39

7.6

6.0

2.8

2.9

2.33

4044

29389

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

940

4162

2.41

124.56

9.1

7.6

mmol/l

24.4

24.8

1.97

927

4122

(40758558) Short blood count panel - Blood

2630

16931

1.79

123.82

8.7

6.8

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1764

10028

1.95

122.99

3.1

2.5

g/l

2.2

2.3

3.89

1631

9260

(3022096) Basophils/100 leukocytes in Blood

4181

30727

1.69

121.67

7.7

6.1

0.6

0.7

2.84

3935

28554

(3006315) Basophils [#/volume] in Blood

4516

33941

1.69

120.21

7.5

5.8

e9/l

0.0

2.30

3950

29132

(3019198) Lymphocytes [#/volume] in Blood

4591

34757

1.68

117.98

7.6

5.9

e9/l

1.9

0.23

4077

30398

(3001604) Monocytes [#/volume] in Blood

4486

33775

1.68

117.58

7.5

5.8

e9/l

0.6

12.41

3935

28967

(3002030) Lymphocytes/100 leukocytes in Blood

4366

32653

1.68

117.29

7.8

6.1

25.4

27.3

24.67

4107

30271

(3003396) Base excess in Arterial blood by calculation

1514

8296

2.00

116.80

10.8

7.3

mmol/l

0.7

1.0

1.83

1230

6422

(3024354) Oxygen [Partial pressure] in Venous blood

1097

5325

2.21

116.73

4.9

3.2

kpa

4.7

4.6

1.24

1055

5129

(3015377) Calcium [Moles/volume] in Serum or Plasma

3260

22625

1.71

115.77

3.9

3.4

mmol/l

2.3

2.4

16.99

2893

19588

(3027801) Oxygen [Partial pressure] in Arterial blood

1513

8318

1.99

115.50

10.8

7.3

kpa

11.8

12.3

3.13

1444

7895

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1512

8325

1.99

114.87

10.9

7.3

kpa

5.0

5.1

0.74

1446

7910

(3018010) Neutrophils/100 leukocytes in Blood

4300

32143

1.67

114.81

7.5

5.9

59.5

57.6

21.38

4059

29940

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2188

13586

1.82

114.70

4.7

3.8

ng/l

212.3

547.1

3.90

1742

10947

(3028026) IgM [Mass/volume] in Serum or Plasma

839

3658

2.43

114.64

2.0

1.9

g/l

1.3

1.4

0.50

777

3328

(3013115) Eosinophils [#/volume] in Blood

4607

35069

1.67

114.53

7.9

6.0

e9/l

0.2

0.90

4076

30599

(3016502) Oxygen saturation in Arterial blood

1383

7435

2.02

112.19

11.4

7.7

95.4

95.5

0.48

1343

7136

(40768797) Stomach Pathology biopsy report

1574

8892

1.94

110.52

1.4

1.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

5724

46388

1.68

109.17

5.4

4.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1410

7703

1.99

109.03

1.9

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1411

7721

1.99

108.56

1.9

1.7

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1276

6797

2.03

105.70

12.1

8.2

g/l

119.0

122.1

5.38

1235

6536

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

347

986

3.62

102.91

1.1

iu/ml

60.4

11168.8

0.54

213

(3017143) Hepatitis C virus Ab [Presence] in Serum

1255

6711

2.02

102.62

1.7

1.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

375

1127

3.43

102.06

1.8

1.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1919

11812

1.80

101.79

3.3

2.8

e6/l

1.1

0.00

1106

6784

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1810

10997

1.82

100.04

3.5

3.0

e6/l

3.1

1.9

4.33

999

6017

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3614

26521

1.62

98.65

2.8

2.2

nmol/l

71.8

77.4

26.99

3270

23660

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3800

28392

1.60

95.17

2.3

2.0

pmol/l

92.3

95.0

2.98

2205

14911

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3667

27305

1.59

92.23

3.6

2.8

ug/l

172.3

149.8

2.65

3363

25096

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

836

4004

2.20

90.84

1.6

1.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

1384

8031

1.86

87.55

2.1

1.8

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1766

11071

1.75

86.07

2.5

2.1

30.5

29.9

2.53

1708

10734

(3002256) Pathology report gross observation

1395

8194

1.84

84.61

1.3

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

794

3845

2.17

83.66

13.5

9.5

mmol/l

23.9

24.3

2.11

747

3555

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1337

7809

1.84

82.40

1.7

1.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

821

4077

2.12

80.98

1.8

1.7

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

880

4517

2.05

79.39

13.6

9.2

1.4

1.21

875

4487

(3048689) Calprotectin [Mass/mass] in Stool

1220

7035

1.85

78.01

3.4

2.3

ug/g

196.0

141.4

3.75

1031

5502

(3022217) INR in Platelet poor plasma by Coagulation assay

1560

9682

1.74

77.88

24.9

26.1

inr

1.3

1.4

0.65

260

1347

(3019309) Folate [Moles/volume] in Red Blood Cells

2004

13323

1.66

77.36

2.0

1.7

nmol/l

1165.8

1154.9

0.20

1592

9957

(3007164) IgA [Mass/volume] in Serum or Plasma

1779

11541

1.68

75.19

1.7

1.5

g/l

2.9

2.5

8.03

1144

7001

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2123

14442

1.62

74.29

2.0

1.7

mg/l

1.6

1.3

2.71

1667

11048

(3021960) Folate [Moles/volume] in Serum or Plasma

2298

15966

1.60

73.54

1.7

1.5

nmol/l

19.6

20.0

0.55

2022

13660

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

466

1900

2.53

72.75

1.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

620

2876

2.24

72.35

2.4

1.9

ug/l

2.8

2.3

0.50

551

2516

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

862

4549

1.99

71.65

4.3

3.6

kpa

5.1

0.72

797

4184

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2910

21440

1.54

71.44

2.5

2.2

u/l

227.5

232.5

0.11

2731

20093

(3021589) Normoblasts [#/volume] in Blood

3820

29818

1.50

71.21

15.0

9.5

e9/l

0.0

0.83

3201

24282

(3009343) pH of Capillary blood

850

4490

1.99

70.41

4.3

3.6

7.4

0.15

131

542

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

142

271

5.31

70.40

2.4

2.0

umol/l

89.9

137.6

1.22

143

(3027923) C peptide [Moles/volume] in Serum or Plasma

162

352

4.67

69.04

1.4

1.3

nmol/l

0.9

1.2

3.40

130

269

(3037522) Nuclear Ab [Titer] in Serum

1363

8422

1.73

68.25

1.5

1.3

titre

395.5

507.3

1.63

296

1670

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1340

8242

1.74

68.20

4.1

4.3

u/l

249.8

245.0

0.30

1252

7750

(3035350) Ketones [Presence] in Urine by Test strip

4090

32556

1.48

68.13

4.4

3.5

estimate

0.0

0.22

878

5832

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

821

4337

1.99

67.90

4.2

3.5

mmol/l

1.6

1.7

0.45

596

3200

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1189

7077

1.79

67.79

4.9

3.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

760

3916

2.03

67.40

14.7

9.9

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

897

4911

1.92

66.74

5.0

4.0

ng/l

110.8

94.9

3.10

774

4209

(3004119) Hemoglobin [Mass/volume] in Venous blood

806

4279

1.97

65.62

4.6

3.4

g/l

128.2

129.7

0.97

779

4174

(3013707) Erythrocyte sedimentation rate by Westergren method

5834

50075

1.50

65.11

5.0

4.0

mm/h

15.7

12.2

42.43

5432

46214

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

548

2534

2.24

64.27

3.1

2.9

u/ml

0.3

3.26

297

1447

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

158

358

4.48

63.94

1.1

1.0

—

(3021601) Nitrite [Presence] in Urine by Test strip

4068

32616

1.46

63.68

5.9

4.8

estimate

0.0

0.80

903

5963

(3006922) Hepatitis E virus Ab [Presence] in Serum

162

376

4.37

63.59

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

158

360

4.45

63.49

1.1

1.0

—

(3009261) Glucose [Presence] in Urine by Test strip

4095

32997

1.46

61.72

4.5

3.6

estimate

0.0

0.54

844

5748

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

439

1879

2.41

61.58

3.1

2.5

g/l

3.7

3.6

1.00

416

1779

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

651

3276

2.07

61.42

1.8

1.7

g/l

1.6

1.07

565

2770

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

637

3200

2.07

60.35

4.0

2.8

0.7

0.6

0.32

620

3053

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

538

2551

2.18

59.22

2.5

2.4

ug/l

431.5

687.5

1.25

511

2405

(3027945) Reticulocytes/100 erythrocytes in Blood

1295

8178

1.69

59.11

2.9

2.4

1.9

1.8

7.42

1151

7168

(3019060) Gas panel - Arterial blood

850

4806

1.85

56.81

6.5

4.7

—

(1616796) Gas panel - Central venous blood

371

1525

2.50

56.80

4.5

3.8

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

974

5747

1.78

56.55

2.3

nmol/l

354.8

373.3

1.73

895

5294

(3027315) Oxygen [Partial pressure] in Blood

377

1578

2.45

55.50

5.9

4.1

kpa

8.8

8.5

1.85

367

1534

(3012501) Base excess in Blood by calculation

375

1572

2.45

55.03

5.8

4.1

mmol/l

2.5

0.07

268

1050

(3013290) Carbon dioxide [Partial pressure] in Blood

375

1573

2.45

54.95

5.8

4.1

kpa

4.9

5.0

1.01

365

1530

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

7462

68403

1.64

54.73

30.1

14.2

mg/l

35.6

24.9

90.85

6864

54170

(3022145) Colonoscopy Study observation

1168

7327

1.69

54.31

1.6

1.3

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2708

20532

1.46

54.12

3.3

3.1

ng/l

1767.1

1554.8

1.27

2371

17633

(3024928) Oxygen saturation in Venous blood

356

1469

2.48

54.05

4.1

3.4

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

125

6.78

53.70

2.1

5.4

u/l

187.4

41.1

1.55

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1048

6408

1.72

53.52

2.6

2.3

ug/l

5.0

8.1

11.40

910

5592

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

240

813

3.01

53.44

1.1

g/l

1.6

1.5

1.69

210

740

(3010421) pH of Blood

413

1831

2.32

53.41

5.6

4.1

7.4

0.04

365

1533

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

331

1337

2.53

52.57

5.8

5.6

iu/ml

895.5

731.3

0.23

205

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

449

2076

2.23

52.52

2.3

1.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1769

12380

1.54

51.96

3.6

3.1

mmol/l

2.5

4.98

1533

10782

(3028626) Oxygen [Partial pressure] in Capillary blood

363

1552

2.40

50.98

3.6

3.0

kpa

8.2

8.0

0.87

335

1434

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

406

1834

2.27

50.22

5.1

3.1

mg/l

1.8

1.6

5.08

366

1660

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

432

2004

2.22

50.10

2.6

2.2

84.9

90.5

4.46

408

1874

(3052851) Hemolysis interference index of Serum or Plasma

432

2031

2.19

48.45

5.0

3.2

—

(3020891) Body temperature

552

2847

2.00

48.40

6.6

4.7

—

(3023520) Reticulocytes [#/volume] in Blood

991

6137

1.69

47.98

3.0

2.5

e9/l

73.3

69.2

2.54

750

4644

(3020191) Ethanol [Moles/volume] in Serum or Plasma

184

570

3.28

47.68

2.1

1.3

promille

1.9

1.3

3.62

135

444

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

261

985

2.70

47.57

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

392

1792

2.24

47.10

2.7

2.5

218.8

193.2

5.12

374

1705

(3026493) Urate [Moles/volume] in Serum or Plasma

2485

18923

1.44

47.08

3.1

2.7

umol/l

3063.6

4860.8

1.61

2178

16381

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1807

12979

1.50

46.18

1.3

u/ml

1.8

2.0

0.22

469

3427

(3018405) Lactate [Moles/volume] in Arterial blood

497

2514

2.04

45.97

5.7

4.0

mmol/l

1.5

1.4

0.49

488

2475

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

165

489

3.42

45.89

1.4

1.1

titre

95.0

97.4

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

165

489

3.42

45.89

1.4

1.1

titre

205.4

170.0

0.18

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

911

5599

1.70

45.23

5.4

3.9

mmol/l

1.2

7.81

844

4865

(3009445) Proteinase 3 Ab [Units/volume] in Serum

558

2961

1.95

45.01

1.5

1.6

u/ml

9.1

20.4

1.46

(3015235) Bicarbonate [Moles/volume] in Capillary blood

387

1798

2.21

44.68

3.6

3.1

mmol/l

24.3

24.8

1.28

341

1553

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

251

961

2.66

44.48

8.1

6.0

mg/l

11.9

11.6

0.65

233

886

(3036489) Thrombin time

481

2454

2.02

43.41

2.4

2.1

22.3

21.4

1.86

437

2152

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1980

14668

1.45

42.74

1.9

1.7

pmol/l

19530724.8

29832497.5

0.46

1618

12148

(3020630) Protein [Mass/volume] in Serum or Plasma

940

5921

1.66

42.37

2.2

2.5

g/l

65.8

66.4

1.28

862

5338

(3016650) Hepatitis A virus Ab [Presence] in Serum

247

962

2.61

42.30

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

158

482

3.32

42.00

1.3

mmol/l

11.6

11.8

0.10

114

127

(3028707) Methadone [Presence] in Urine by Screen method

221

824

2.73

41.27

3.5

2.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

378

1805

2.14

40.71

1.4

1.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

283

1198

2.41

40.63

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

742

4455

1.73

39.92

1.5

1.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

7609

71104

1.56

39.91

33.0

16.5

mmol/l

138.8

139.7

128.83

7472

69259

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

267

1110

2.45

39.89

1.3

1.2

u/ml

301.8

278.1

0.59

171

688

(3000494) Fungus identified in Specimen by Culture

1170

7882

1.56

39.73

1.7

1.4

—

(40767503) Oxygen content in Capillary blood by calculation

327

1492

2.24

39.45

3.4

2.5

15.8

16.4

1.46

172

768

(3008152) Bicarbonate [Moles/volume] in Arterial blood

754

4567

1.71

39.27

9.9

6.9

mmol/l

24.3

24.6

1.06

708

4239

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

452

2337

1.99

39.24

1.7

1.6

titre

143.3

315.9

1.50

102

(46235355) HIV 1 and 2 tests - Meaningful Use set

1367

9554

1.51

39.14

1.9

1.8

—

(3029937) Albumin [Presence] in Urine by Test strip

2289

17661

1.40

38.74

5.2

4.0

estimate

0.0

0.24

834

5653

(3011397) Hemoglobin [Presence] in Urine by Test strip

2049

15511

1.42

38.68

4.2

3.6

—

(40768441) Liver Pathology biopsy report

138

410

3.40

38.29

2.0

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

597

3411

1.81

38.08

5.1

3.4

mmol/l

24.7

25.2

2.64

578

3295

(3022313) Gas panel - Capillary blood

582

3303

1.82

37.96

4.5

3.6

—

(3028271) Lactate [Moles/volume] in Capillary blood

265

1124

2.40

37.89

2.3

1.9

mmol/l

1.8

1.7

0.57

258

1096

(3048929) Epstein Barr virus Ab [Presence] in Serum

353

1689

2.14

37.82

1.3

1.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

378

1860

2.08

37.63

1.6

1.4

iu/ml

6.2

17.1

—

(3017181) Myelocytes/100 leukocytes in Blood

894

5725

1.63

37.51

4.0

4.1

1.0

0.30

307

1659

(3023103) Potassium [Moles/volume] in Serum or Plasma

7612

71321

1.54

37.41

33.2

16.7

mmol/l

4.0

6.56

7474

69350

(3003181) Sodium [Moles/volume] in Urine

271

1169

2.36

37.31

1.5

1.3

mmol/l

61.2

63.8

0.38

196

940

(3013512) EKG study

2557

20196

1.38

37.30

4.8

4.0

—

(3051651) Icteric interference index of Serum or Plasma

132

389

3.43

37.10

5.6

3.3

—

(3025941) Bacteria identified in Stool by Culture

602

3486

1.78

36.68

1.3

1.2

—

(3021901) Oxygen saturation in Capillary blood

288

1285

2.28

36.66

3.5

2.9

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

553

3148

1.81

35.67

5.6

4.0

49.9

48.2

0.82

542

3110

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

151

505

3.03

34.49

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

254

3.93

34.14

3.5

2.6

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

9.56

34.12

1.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

311

1479

2.14

33.85

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

311

1479

2.14

33.85

1.5

1.3

—

(3042517) Benzodiazepines panel - Urine

9.34

33.54

4.0

2.3

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

192

742

2.62

33.46

3.6

3.2

nmol/l

7.1

14.1

0.45

184

727

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

483

2690

1.84

33.43

2.1

1.8

—

(3004588) Protein electrophoresis panel - Serum or Plasma

768

4880

1.63

33.09

2.0

2.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1899

14561

1.39

32.35

5.4

4.5

—

(3011288) Drugs identified in Urine by Screen method

267

1220

2.23

32.13

3.9

3.0

—

(3021440) Promyelocytes/100 leukocytes in Blood

834

5455

1.58

31.82

4.1

0.1

0.44

279

1537

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

511

2944

1.78

31.61

2.2

2.0

—

(3002179) Metamyelocytes/100 leukocytes in Blood

804

5223

1.59

31.56

3.9

4.0

0.6

0.7

0.76

228

1221

(40761536) Microorganisms panel - Urine sediment

838

5501

1.58

31.46

5.0

3.9

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

225

965

2.37

31.42

1.2

1.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5573

50035

1.32

31.37

4.2

3.7

pmol/l

14.8

0.37

5021

45172

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

269

1247

2.19

31.24

1.7

1.5

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

234

1025

2.32

31.14

3.3

2.7

u/ml

2416.3

1892.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

249

1125

2.25

30.80

1.6

1.5

u/ml

123.2

113.4

0.25

238

(3026250) Tacrolimus [Mass/volume] in Blood

270

3.66

30.56

40.7

34.1

ug/l

7.0

7.4

0.95

248

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

496

2865

1.78

30.40

4.8

3.7

mmol/l

24.5

24.8

0.98

461

2611

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

266

1244

2.17

30.23

1.6

1.4

u/ml

23.1

17.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3038

25259

1.31

29.67

4.9

3.8

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

239

3.75

28.83

1.8

2.2

e6/l

1134.3

4086.2

0.42

162

(3047181) Lactate [Moles/volume] in Blood

406

2248

1.85

28.61

8.0

6.0

mmol/l

1.6

1.3

4.28

347

1972

(3025159) Blasts/100 leukocytes in Blood

774

5132

1.56

27.68

4.2

0.0

0.4

1.80

232

1319

(3051611) Lipemic interference index of Serum or Plasma

172

694

2.51

27.49

5.3

3.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

837

5690

1.52

26.67

3.4

2.6

ml/min/173m2

63.8

65.4

0.42

340

2239

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

163

654

2.52

26.38

1.2

u/l

59.2

67.2

0.86

120

443

(3033799) Differential panel - Peritoneal fluid

217

3.76

26.36

1.9

1.8

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

285

1446

2.00

26.12

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

284

1446

2.00

25.77

3.1

2.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6820

63619

1.33

25.62

8.0

5.8

mmol/mol

43.7

40.0

97.65

6369

58680

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

6618

61484

1.32

25.49

5.1

4.4

mu/l

1.9

2.2

2.30

6045

55871

(4035726)

866

5984

1.50

25.47

1.5

1.4

—

(3019225) pH of Specimen

969

6868

1.46

25.06

5.4

4.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

277

1416

1.99

24.86

1.6

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

486

2963

1.68

24.48

7.8

5.1

1.8

1.7

0.84

456

2760

(3007930) Methemoglobin/Hemoglobin.total in Blood

479

2912

1.68

24.39

7.8

5.2

0.9

0.35

450

2716

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

9.38

24.39

1.1

1.0

u/l

39.1

48.9

0.33

(3044889) 12 lead EKG panel

5398

48976

1.27

24.23

4.5

3.8

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

384

2213

1.77

23.71

2.6

3.2

ratio

1.2

3.9

1.83

162

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

215

3.60

23.63

1.8

2.0

e6/l

10284.2

18526.0

0.33

113

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

187

839

2.26

23.61

1.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

6901

64687

1.32

23.59

25.7

13.4

ml/min/173m2

80.7

79.7

2.92

6045

53548

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

392

2276

1.76

23.58

2.6

3.2

mg/l

48.9

49.6

0.02

309

1842

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

189

855

2.24

23.39

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

187

843

2.24

23.34

1.4

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

311

1691

1.87

23.24

1.6

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

391

2280

1.75

23.17

2.6

3.2

mg/l

77.2

80.7

0.04

309

1845

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

354

2017

1.79

22.73

1.7

1.6

iu/ml

0.3

5.1

0.99

459

(3025468) Yersinia sp identified in Specimen by Organism specific culture

184

835

2.23

22.62

1.4

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

184

838

2.22

22.42

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

374

2178

1.75

22.27

5.9

4.2

mmol/l

3.9

0.63

354

2053

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

183

836

2.21

22.14

1.4

—

(4198724)

237

3.35

21.76

1.9

1.6

—

(3040151) Glucose [Moles/volume] in Capillary blood

175

792

2.23

21.67

47.1

6.6

mmol/l

8.9

7.3

1.21

146

651

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

298

1643

1.84

21.33

1.6

1.7

—

(40760888) Immunoglobulin light chains.free panel - Serum

308

1720

1.82

21.15

2.7

3.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2184

18013

1.28

20.98

1.8

1.6

mmol/l

1.7

1.4

9.17

1884

15071

(3016879) Cocaine [Presence] in Urine

311

1747

1.81

20.95

3.0

2.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

268

3.16

20.95

1.7

1.5

iu/ml

2700022.2

1775063.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

238

1229

1.96

20.81

1.6

1.7

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

173

796

2.20

20.59

1.5

1.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

311

1759

1.80

20.49

2.2

2.4

ug/min

176.5

113.4

1.07

178

1064

(3000764) Benzodiazepines [Presence] in Urine

326

1874

1.77

20.33

3.0

2.1

—

(40768804) Tissue Pathology biopsy report

3121

26930

1.25

20.32

2.3

2.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

287

1596

1.83

20.00

2.9

2.2

g/l

126.2

129.9

1.35

226

1132

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

114

444

2.59

19.73

1.1

1.0

mg/l

281.0

284.2

0.18

104

400

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

235

1231

1.93

19.72

1.3

1.2

—

(3028300) Cannabinoids [Presence] in Urine

326

1891

1.75

19.71

3.0

2.1

—

(3019150) Specific gravity of Urine by Refractometry

1783

14427

1.30

19.68

5.0

4.0

kg/l

1.0

0.28

252

2108

(3044007) Cell count panel - Peritoneal fluid

198

3.45

19.65

2.1

1.8

—

(3019977) pH of Arterial blood

104

389

2.69

19.51

3.9

2.8

7.4

0.06

140

(3027008) Opiates [Presence] in Urine

324

1887

1.74

19.32

2.9

2.0

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

555

3698

1.53

19.28

3.3

2.9

e6/l

0.4

0.3

0.90

546

3609

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

846

6146

1.42

18.91

3.1

2.9

ng/l

240.5

216.8

0.79

780

5574

(3041096) Erythrocytes [Presence] in Urine by Automated

2100

17427

1.27

18.84

4.3

3.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

308

1783

1.75

18.77

1.3

1.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

331

1956

1.72

18.75

1.5

1.6

g/l

1.2

3.38

320

1851

(3014765) Yersinia sp identified in Stool by Organism specific culture

309

1799

1.74

18.46

1.3

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

434

2767

1.60

18.30

1.7

2.3

g/l

7.4

0.27

328

2062

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

408

2566

1.62

18.20

1.7

2.3

g/l

10.9

10.2

1.80

342

2155

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

433

2763

1.60

18.19

1.7

2.3

g/l

4.0

3.8

1.95

316

1978

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

319

1883

1.72

18.15

1.5

1.6

g/l

0.2

1.87

308

1780

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

433

2765

1.60

18.13

1.7

2.3

—

(3002385) Erythrocyte distribution width [Ratio]

6015

56009

1.24

18.08

33.3

17.3

14.1

13.7

53.99

5912

54721

(42529406) Shigella sp [Presence] in Stool by Culture

309

1810

1.73

18.07

1.3

1.2

—

(3027944) Amphetamines [Presence] in Urine

314

1849

1.72

18.02

2.8

2.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

283

1626

1.77

17.72

1.6

—

(3042733) HLA Ab [Presence] in Serum

222

3.17

17.70

5.2

5.3

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

369

2.65

17.65

1.2

u/l

46.5

22.0

1.66

310

(3034274) Bile acid [Moles/volume] in Serum --fasting

103

405

2.56

17.54

2.0

1.8

umol/l

21.4

8.2

2.47

280

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

381

2.59

17.09

1.2

u/l

127.4

83.2

2.50

326

(3022493) Free Hemoglobin [Mass/volume] in Plasma

298

2.80

16.90

4.4

5.0

mg/l

2455.0

888.0

0.27

211

(21494755) Public health laboratory ask at order entry panel

400

6109

0.64

16.88

1.3

1.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

406

2600

1.59

16.81

1.8

2.3

g/l

3.2

3.1

1.61

319

2019

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

404

2590

1.59

16.65

2.4

2.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

189

985

1.94

16.18

1.5

—

(40768446) Kidney Pathology biopsy report

278

2.82

16.12

1.9

1.6

—

(40761535) Cells panel - Urine sediment

787

5808

1.39

15.98

4.1

3.5

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

138

3.64

15.73

1.6

1.3

—

(3037756) Immunofixation for Serum or Plasma

253

1464

1.75

15.50

1.4

1.6

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

311

1904

1.66

15.48

1.7

2.3

g/l

0.0

0.00

288

1742

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

371

2375

1.59

15.40

2.0

2.4

g/l

0.5

1.0

2.89

321

2020

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

220

1232

1.81

15.08

1.4

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

237

1357

1.77

15.07

4.0

3.7

60.1

58.0

1.88

237

1357

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

313

1938

1.64

14.91

1.7

2.3

g/l

0.0

1.04

288

1750

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

379

2.47

14.76

2.3

1.7

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

211

1176

1.81

14.70

4.2

3.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

208

1155

1.82

14.67

2.9

3.5

1.1

1.5

2.01

161

876

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

331

2089

1.61

14.60

1.8

2.3

g/l

0.0

0.21

306

1895

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

340

2161

1.60

14.57

1.7

2.2

g/l

36.5

37.6

2.47

299

1844

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

154

777

2.00

14.52

2.1

1.7

—

(3037121) Protein [Mass/volume] in Urine

368

2408

1.55

13.91

3.4

3.2

g/l

0.4

0.3

1.25

181

1084

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

140

694

2.03

13.88

2.9

3.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

266

1610

1.67

13.87

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

182

993

1.85

13.61

1.4

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

277

1705

1.65

13.54

1.2

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

384

2.38

13.43

1.7

1.6

u/l

5.0

5.5

0.13

188

(3016038) Potassium [Moles/volume] in Urine

434

2.30

13.40

1.4

1.1

mmol/l

30.9

35.4

1.24

377

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

101

447

2.27

13.37

1.3

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7592

73243

1.29

13.37

19.3

10.0

u/l

32.5

26.8

27.48

7420

70436

(3008757) Leukocyte morphology finding [Identifier] in Blood

148

760

1.96

13.31

4.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

286

2.60

13.16

29.6

26.6

ug/l

121.8

113.0

0.67

240

(36660697) Celiac disease serology panel - Serum

635

4675

1.39

13.04

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

347

2276

1.55

13.00

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

119

572

2.10

12.85

1.4

1.5

—

(40761511) CBC panel - Blood by Automated count

7389

71123

1.26

12.75

26.3

13.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

438

2.25

12.70

1.2

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

388

2.33

12.68

1.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

170

3.07

12.61

1.4

1.8

g/l

8.7

14.0

3.78

137

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4348

39946

1.18

12.33

2.9

2.7

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

210

1235

1.72

12.23

2.4

2.2

u/l

2077.9

4588.1

0.98

469

(3004716) Salmonella sp identified in Stool by Organism specific culture

413

2849

1.47

12.17

1.3

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

8.84

11.99

1.2

mmol/l

—

(3023199) Leukocytes [#/volume] in Pleural fluid

164

910

1.82

11.69

1.5

e6/l

7575.9

2050.9

0.50

122

656

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

138

3.20

11.46

2.1

2.6

—

(3023419) Bacteria identified in Sputum by Culture

163

913

1.80

11.28

2.2

2.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

340

2.34

11.23

1.3

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

340

2.34

11.23

1.3

1.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

110

3.47

11.22

6.2

5.3

—

(3012441) Differential panel - Pleural fluid

147

799

1.85

11.21

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

413

5778

0.70

11.06

1.8

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

200

2.71

10.52

3.1

3.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

200

2.71

10.52

3.1

3.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

182

1075

1.71

10.50

1.5

1.4

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

189

2.76

10.50

2.9

3.1

mg/l

9.6

8.0

0.84

156

(3003434) Protein [Mass/volume] in Pleural fluid

177

1038

1.72

10.48

1.5

g/l

30.8

32.2

0.72

157

925

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

4.80

10.46

2.9

2.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

145

803

1.82

10.45

1.4

1.5

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

402

2846

1.43

10.37

1.7

1.9

u/l

38.8

39.0

0.05

355

2485

(3003694) ABO and Rh group [Type] in Blood

2105

18408

1.19

10.29

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1286

10726

1.23

10.29

1.3

iu/ml

47.4

34.8

1.01

390

3366

(3036782) Glucose [Moles/volume] in Pleural fluid

129

693

1.87

10.25

1.3

1.4

mmol/l

7.0

6.2

1.59

119

632

(3039000) Anion gap in Blood

251

1620

1.57

10.18

10.9

6.9

mmol/l

11.9

11.3

1.76

224

1440

(3018572) Chloride [Moles/volume] in Blood

251

1621

1.56

10.16

10.9

6.9

mmol/l

104.2

105.1

1.82

224

1441

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

312

2.32

10.12

1.1

u/l

59.1

29.2

0.72

237

(3024932) HLA-DR beta [Type]

228

2.55

10.06

1.0

1.1

—

(3024471) HLA-A [Type]

234

2.53

10.05

1.0

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

313

2.31

10.05

1.1

u/l

111.8

89.9

0.44

245

(3028308) Erythrocytes [#/volume] in Pleural fluid

148

836

1.78

10.01

1.5

e6/l

38331.5

57137.0

0.56

487

(3014148) Varicella zoster virus Ab [Titer] in Serum

131

713

1.85

10.00

1.2

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

151

2.92

9.88

1.4

1.3

g/l

19.4

27.0

1.92

114

(3045788) Cell count panel - Pleural fluid

127

691

1.85

9.72

1.6

1.5

—

(3008295) Osmolality of Serum or Plasma

125

677

1.86

9.70

1.5

1.4

mosm/kgh2o

285.7

278.6

1.58

526

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

129

706

1.84

9.69

1.3

u/l

882.3

432.1

0.56

117

669

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

161

943

1.72

9.62

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

250

3741

0.66

9.58

1.4

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

117

624

1.89

9.53

2.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

114

603

1.90

9.53

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

184

1120

1.66

9.53

1.2

1.4

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.79

9.47

1.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

341

2.21

9.44

3.5

2.0

—

(4010399)

639

4947

1.31

9.43

1.4

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

3.87

9.38

1.1

2.0

mmol/l

1.1

0.9

0.14

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

189

1164

1.64

9.35

1.1

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

343

2.20

9.31

1.9

1.8

u/field

1.9

2.5

0.39

253

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

185

2.66

9.24

2.4

2.0

mg/l

8.6

9.2

0.37

150

(3045716) Anion gap in Serum or Plasma

314

2.24

9.12

2.8

2.5

mmol/l

9.9

9.1

0.73

236

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

223

2.48

8.99

1.5

1.9

—

(3020961) Endomysium IgA Ab [Titer] in Serum

374

2685

1.41

8.97

1.1

titre

40.0

230.6

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

171

2.70

8.95

2.4

2.6

au/ml

130.4

175.2

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

3.42

8.74

1.3

1.2

u/l

1313.5

82.7

0.65

(3023511) Choriogonadotropin [Units/volume] in Urine

108

579

1.88

8.70

1.6

1.3

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

3.55

8.65

2.0

1.8

pmol/l

36.2

49.0

0.45

(40761539) Cells [Type] in Urine sediment by Light microscopy

169

2.67

8.60

1.3

1.2

—

(3008037) Lactate [Moles/volume] in Venous blood

232

1533

1.53

8.54

4.6

3.1

mmol/l

1.7

1.6

0.44

223

1496

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

278

1909

1.47

8.49

1.7

1.8

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

135

785

1.73

8.34

1.2

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

150

902

1.67

8.20

1.1

122.8

116.0

1.79

130

808

(3012565) Volume of 24 hour Urine

337

2.12

8.09

2.0

2.3

2143.9

1983.3

0.42

291

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

120

686

1.76

7.89

1.2

1.1

96.1

97.2

0.19

107

639

(3016273) Islet cell 512 Ab [Units/volume] in Serum

4.86

7.87

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

302

2.16

7.83

3.7

3.1

—

(3017569) Oxygen content in Arterial blood

342

2.08

7.80

3.9

2.2

—

(3014271) Vancomycin [Susceptibility]

376

2.03

7.78

3.5

2.9

—

(3004451) EKG impression Narrative

336

2.09

7.76

1.4

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

452

1.93

7.75

1.4

1.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

329

2378

1.40

7.64

1.2

u/ml

0.7

0.9

0.24

234

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

241

2.29

7.64

2.4

1.9

u/ml

388.9

39669.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

204

2.41

7.63

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

152

937

1.63

7.58

1.1

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

7.34

7.55

1.0

u/field

1.3

1.5

0.22

(3006270) Folate [Moles/volume] in Blood

105

586

1.80

7.51

1.2

nmol/l

325.0

350.9

0.68

483

(4306422)

151

933

1.63

7.47

1.2

—

(1761868) Lipid panel - Serum or Plasma

2171

24109

0.87

7.38

3.3

2.9

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

477

3672

1.32

7.38

3.1

3.3

pmol/l

4.4

4.5

0.72

406

3266

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

405

1.96

7.34

1.4

1.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

215

2.33

7.27

1.1

—

(3004775) Volume in Urine collected for unspecified duration

101

564

1.80

7.23

2.1

2.3

698.9

660.1

0.42

375

(3017354) Segmented neutrophils/100 leukocytes in Blood

123

730

1.69

7.12

2.6

3.5

62.0

58.2

1.19

464

(3003327) Ova and parasites identified in Stool by Light microscopy

273

1936

1.42

7.10

1.8

1.7

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

5.66

7.06

4.4

1.4

—

(44790048)

129

778

1.67

7.04

1.6

1.4

—

(44806118)

129

778

1.67

7.04

1.6

1.4

—

(44790047)

129

778

1.67

7.04

1.6

1.4

—

(44790049)

129

778

1.67

7.04

1.6

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

131

797

1.65

6.92

1.2

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

407

1.92

6.91

1.4

1.5

—

(40768443) Skin Pathology biopsy report

394

2986

1.33

6.82

1.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

382

1.95

6.78

2.1

2.3

umol/l

31.4

18.5

—

(4281824)

106

613

1.74

6.76

1.2

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

143

2.59

6.76

2.9

2.7

—

(3042631) Mycobacterium sp identified in Specimen

160

1030

1.56

6.72

2.4

2.8

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1172

10080

1.19

6.67

1.3

1.2

u/ml

9.9

13.3

0.89

420

3840

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

150

954

1.58

6.64

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

228

1586

1.45

6.61

1.2

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

113

670

1.70

6.60

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

150

956

1.58

6.58

1.3

1.2

u/ml

4.4

3.9

0.20

416

(3035880) pH of Pleural fluid

409

1.89

6.50

1.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

127

781

1.64

6.46

1.2

1.3

nmol/l

—

(3010838) Calcium [Moles/time] in 24 hour Urine

313

2.02

6.45

1.2

1.7

mmol/24h

4.1

7.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

256

1829

1.41

6.42

1.8

1.9

mg/l

11.6

11.4

0.13

238

1699

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

268

2.10

6.34

1.5

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

406

1.88

6.31

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

151

975

1.56

6.28

1.3

1.2

u/ml

4.0

3.2

0.19

308

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

151

975

1.56

6.28

2.3

1.9

ug/l

19.9

25.3

0.86

146

956

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

117

711

1.65

6.25

3.6

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

538

1.76

6.25

1.5

1.7

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

174

1162

1.51

6.21

1.2

1.3

u/l

22.7

37.7

2.51

152

1000

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

162

2.41

6.17

1.1

76.5

85.0

0.63

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

122

755

1.62

6.08

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

122

755

1.62

6.08

1.6

2.0

—

(3044927) Protein electrophoresis panel - Urine

118

726

1.63

6.03

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

105

627

1.68

6.01

1.3

1.5

—

(3011985) Renin [Units/volume] in Plasma

137

877

1.57

5.95

1.5

1.4

mu/l

66.7

59.8

0.17

124

771

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

106

2.74

5.93

8.4

12.1

mmol/l

5.6

5.9

0.31

106

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

159

2.40

5.93

1.1

1.2

83.3

83.7

0.01

(3016750) Collection duration of Urine

401

1.85

5.91

1.8

2.3

min

493.7

491.9

0.04

291

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

172

2.33

5.88

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

185

2.28

5.85

1.5

—

(3049717) Cytology report of Urine Cyto stain

380

2938

1.31

5.77

2.6

2.8

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

128

813

1.58

5.76

1.4

1.3

pmol/l

273.9

310.7

0.38

609

(40768806) Pleura Pathology biopsy report

128

817

1.58

5.65

1.6

—

(3035285) Chloride [Moles/volume] in Venous blood

135

874

1.55

5.60

3.2

2.2

mmol/l

105.0

105.6

0.67

135

862

(3017732) Neutrophils [#/volume] in Blood

575

4694

1.24

5.60

3.3

2.9

e9/l

4.6

4.1

2.87

416

3579

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

113

702

1.62

5.58

1.7

1.8

—

(3005322) IgE [Units/volume] in Serum or Plasma

474

3790

1.27

5.54

1.4

1.3

u/ml

244.1

254.7

0.11

440

3490

(3038515) Glucose [Moles/volume] in Venous blood

206

1457

1.42

5.53

4.9

3.2

mmol/l

8.6

7.6

2.48

198

1429

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

368

1.85

5.48

2.5

2.1

ug/min

144.5

180.5

0.18

(4146454)

119

754

1.59

5.43

2.8

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

234

1699

1.39

5.41

1.5

1.4

u/l

9.7

9.2

0.25

180

1379

(3041354) Potassium [Moles/volume] in Venous blood

134

874

1.54

5.40

3.2

2.2

mmol/l

4.1

0.34

134

862

(3042010) Triglyceride [Moles/volume] in Pleural fluid

106

2.65

5.39

1.2

mmol/l

1.7

1.3

0.11

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

349

1.87

5.38

1.2

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

342

1.88

5.37

1.7

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

342

1.88

5.37

1.7

1.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

137

900

1.53

5.34

1.2

1.3

nmol/l

0.2

0.57

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

474

1.74

5.33

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

550

1.68

5.30

1.3

u/l

19.3

13.6

0.49

510

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

366

1.84

5.26

1.8

2.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

366

1.84

5.26

1.7

2.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

366

1.84

5.26

1.8

2.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

366

1.84

5.26

1.8

2.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

118

757

1.57

5.13

1.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

6865

66800

1.13

5.13

5.5

4.6

mmol/l

6.5

6.0

95.57

6269

60717

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

139

2.38

5.12

1.2

1.4

—

(3006576) Bicarbonate [Moles/volume] in Blood

257

1.99

5.10

7.4

6.6

mmol/l

24.7

24.9

0.10

231

(3007463) Buprenorphine [Presence] in Urine

5.27

5.03

8.0

9.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

350

1.83

5.03

1.2

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

3.28

5.01

1.2

1.3

ml/s/173m2

1.6

1.1

1.03

(3033705) Calcium.ionized [Moles/volume] in Venous blood

130

860

1.52

4.94

3.3

2.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

268

1.95

4.90

2.7

2.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

120

782

1.54

4.89

1.1

—

(3021788) Differential panel - Synovial fluid

182

1291

1.42

4.86

1.4

1.5

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

244

1.97

4.71

1.6

1.9

182.7

157.0

1.09

231

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

139

2.31

4.67

1.2

1.1

—

(3022621) pH of Urine by Test strip

527

4353

1.22

4.64

3.3

2.9

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

364

2886

1.27

4.62

1.1

—

(4268621)

101

643

1.58

4.59

2.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

376

1.76

4.57

1.3

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

628

1.58

4.57

1.6

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

628

1.58

4.57

1.6

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

628

1.58

4.57

1.6

1.8

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

213

2.02

4.55

1.4

1.2

ug/l

22.7

422.0

1.64

112

(3020491) Glucose [Moles/volume] in Blood

497

1.66

4.54

1.8

2.0

mmol/l

8.0

6.9

1.68

339

(43055514) Macroprolactin [Presence] in Serum or Plasma

116

2.42

4.53

1.4

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

122

1798

0.67

4.52

1.4

1.6

—

(3009542) Hematocrit [Volume Fraction] of Blood

6405

62224

1.11

4.44

29.6

15.3

38.4

40.0

30.30

4257

43907

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

372

1.75

4.44

1.3

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

230

1724

1.34

4.43

1.8

1.7

mu/l

307.6

289.5

0.35

210

1580

(3044941) Cell count panel - Synovial fluid

153

1073

1.43

4.39

1.5

1.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

211

1563

1.36

4.39

1.1

u/ml

6.2

8.2

0.24

183

(3000492) Spirometry study

759

6523

1.18

4.37

1.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

324

2552

1.28

4.36

2.9

3.7

u/ml

64.4

57.3

0.17

311

2457

(3017704) Immunofixation for Urine

375

1.74

4.33

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

254

1939

1.32

4.32

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

540

4506

1.21

4.32

1.7

1.9

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

594

5005

1.20

4.29

1.8

1.9

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.78

4.27

1.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

158

2.16

4.26

1.1

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

348

1.76

4.23

1.2

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6700

65316

1.11

4.15

4.6

4.0

mmol/l

1.5

1.3

27.84

6140

59609

(3045414) Leukocytes [Presence] in Urine

370

2981

1.25

4.14

1.9

—

(3001186) Copper [Moles/volume] in Serum or Plasma

154

2.15

4.10

2.1

1.1

umol/l

15.8

16.4

0.32

137

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

397

1.69

4.08

1.4

1.5

u/l

5.2

6.7

1.64

338

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

280

1.83

4.03

2.0

2.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

280

1.83

4.03

2.0

2.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

117

2.31

4.00

1.4

1.3

ng/l

180.5

752.6

0.41

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.67

3.98

2.3

2.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

282

1.81

3.95

2.0

2.3

—

(3013727) Leukocytes other/100 leukocytes in Blood

218

1.93

3.94

4.2

3.5

60.9

53.8

1.45

209

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

125

863

1.45

3.94

2.8

2.0

mg/l

19.7

24.3

0.48

224

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

157

2.11

3.92

2.3

2.2

mmol/l

7.5

8.0

0.22

(3033923) Metanephrine [Moles/time] in 24 hour Urine

131

2.22

3.91

1.1

umol/24h

0.6

0.7

0.41

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.72

3.91

2.4

2.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

534

1.58

3.90

2.2

2.0

u/field

2.0

1.7

0.24

224

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

314

1.76

3.84

2.7

2.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

963

8525

1.15

3.77

4.8

4.5

32.1

32.2

0.15

728

5770

(3012920) Ethanol [Mass/volume] in Serum or Plasma

8.76

3.77

2.3

1.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

997

8852

1.14

3.74

11.8

7.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

121

2.24

3.72

1.7

1.6

ng/l

117.0

148.6

0.56

121

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.64

3.72

2.9

2.7

u/field

0.4

0.5

0.15

(3020876) Protein [Mass/time] in 24 hour Urine

653

1.51

3.71

1.9

g/24h

2.3

0.9

—

(3017509) Phencyclidine [Presence] in Urine

3.00

3.68

1.8

1.6

—

(3032057) Clostridioides difficile [Presence] in Stool

148

2.10

3.67

2.9

1.9

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

189

1.96

3.66

1.2

117.8

110.6

1.05

166

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.11

3.64

1.0

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

181

1352

1.35

3.64

2.0

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

104

705

1.48

3.63

2.0

1.4

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

489

1.58

3.62

3.1

2.6

e6/l

576.9

645.2

0.31

192

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

499

1.57

3.56

1.8

2.1

nmol/l

16.3

18.1

1.42

472

(3000475) Leukocytes [#/volume] in Synovial fluid

223

1724

1.30

3.54

1.7

1.6

e6/l

16583.8

16228.5

0.04

167

1243

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.05

3.52

1.0

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

488

4119

1.20

3.51

1.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

5.30

3.50

3.8

2.5

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

5.30

3.50

3.8

2.8

—

(3043410) Blood group antigens tested for on Red Blood Cells

172

1.98

3.47

2.2

1.8

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

495

1.56

3.45

1.5

1.6

u/ml

40.3

24.1

0.91

114

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

333

1.69

3.43

1.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

665

1.48

3.43

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

441

1.59

3.42

1.3

titre

524.0

305.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

244

1.81

3.42

1.3

1.4

—

(3045424) Erythrocytes [Presence] in Urine

153

1126

1.37

3.41

1.6

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1090

9793

1.13

3.41

1.5

1.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

139

1008

1.39

3.39

5.3

4.9

umol/l

354.1

360.3

0.18

121

858

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

373

1.64

3.37

3.4

3.9

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

547

1.52

3.34

1.4

u/l

13.1

12.6

0.25

528

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.25

3.34

1.1

1.3

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

2.78

3.25

3.3

1.5

16.8

18.8

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

417

1.59

3.21

3.9

2.7

e9/l

0.2

2.38

363

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

192

1476

1.31

3.21

2.0

1.3

mmol/l

4.2

3.8

1.32

176

1388

(3007919) Fasciola sp Ab [Titer] in Serum

6.37

3.18

1.0

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

178

1.91

3.18

2.0

1.3

nmol/l

86.5

136.1

2.06

133

(3041918) Cholesterol [Moles/volume] in Pleural fluid

137

2.05

3.15

1.2

mmol/l

1.5

1.6

0.16

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

104

2.21

3.15

1.1

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

296

1.69

3.14

1.2

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

186

1.89

3.13

1.2

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

436

1.56

3.12

3.8

2.6

e6/l

434.2

521.8

1.05

365

(3009871) Measles virus Ab [Titer] in Serum

208

1.83

3.11

1.7

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

421

1.57

3.10

1.4

1.3

titre

33.3

72.8

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

429

3624

1.19

3.10

2.5

2.4

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.45

3.04

1.8

1.6

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

479

1.53

3.04

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

113

2.13

2.99

1.5

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

271

1.70

2.96

1.2

1.1

miu/ml

1371.8

1508.3

0.43

271

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

134

2.02

2.95

1.5

ug/l

0.4

0.18

(3000012) Reticulocyte production index

411

1.56

2.94

1.3

1.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

483

1.52

2.93

2.8

2.5

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

287

1.68

2.93

1.3

1.4

56.0

65.8

0.98

238

(3019420) Tryptase [Mass/volume] in Serum or Plasma

318

1.64

2.92

1.4

1.5

ug/l

8.4

7.9

0.12

278

(1761482) Bacteria [#/volume] in Urine by Culture

227

1808

1.26

2.91

5.3

4.0

—

(3052592) Norovirus Ag [Presence] in Stool

143

1.96

2.84

1.5

1.3

—

(40768800) Prostate Pathology biopsy report

150

1962

0.76

2.83

1.2

—

(3011412) CD3 cells [#/volume] in Blood

636

1.44

2.80

3.3

2.5

e9/l

1.0

1.1

0.99

387

(3002619) Bacteria identified in Specimen by Culture

123

2.04

2.80

1.0

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

2.46

2.78

1.4

1.1

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

110

2.09

2.77

2.1

1.2

101.7

106.9

0.26

103

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2334

24726

0.92

2.77

4.1

4.2

22.3

21.9

0.53

1068

12004

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

187

1467

1.28

2.74

1.2

1.3

miu/ml

189.4

213.9

0.43

648

(3027456) Digoxin [Moles/volume] in Serum or Plasma

180

1407

1.29

2.72

2.9

3.0

nmol/l

0.8

0.34

134

1061

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.71

1.2

1.0

—

(40757373) Influenza virus identified in Isolate

139

1.95

2.69

1.5

1.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1662

17839

0.92

2.69

2.8

3.0

ug/l

0.7

0.8

2.82

1123

11769

(3019897) Erythrocyte distribution width [Ratio] by Automated count

761

0.63

2.68

3.2

3.0

13.4

13.2

0.84

748

(3000034) Microalbumin [Mass/volume] in Urine

676

1.41

2.67

3.0

2.9

mg/l

148.2

53.7

0.89

493

(3030313) Adrenal Ab [Titer] in Serum

3.13

2.64

1.1

—

(3034426) Prothrombin time (PT)

228

1.71

2.62

1.3

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

186

1469

1.27

2.60

2.0

1.4

e6/l

9.7

22.7

1.49

132

1135

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

186

1471

1.27

2.58

2.0

1.4

e6/l

461.4

1180.3

1.62

147

1196

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

121

1.99

2.54

1.3

1.5

10.3

10.0

0.02

(3000330) Specific gravity of Urine by Test strip

400

3425

1.18

2.53

4.4

3.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

371

1.54

2.52

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

461

1.48

2.49

1.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

3.46

2.48

6.4

5.3

umol/l

526.7

421.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.14

2.44

1.2

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

208

1680

1.24

2.43

1.9

1.3

mg/l

499.7

548.4

0.54

197

1594

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

178

1414

1.26

2.40

1.7

1.8

iu/l

3.9

4.6

0.39

488

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

320

1.57

2.39

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

233

2823

0.82

2.34

1.6

1.7

—

(21491868) Cryoglobulin [Mass/volume] in Serum

244

1.64

2.33

1.2

g/l

0.2

0.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

726

6524

1.12

2.32

2.4

2.2

nmol/l

12.5

13.0

0.85

608

5804

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

119

1557

0.76

2.32

1.3

1.4

—

(3025315) Body weight

2.38

2.29

4.6

4.7

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

106

1.98

2.25

1.7

2.1

umol/l

14.7

17.4

0.55

106

(3002814) Trichinella spiralis Ab [Titer] in Serum

5.56

2.21

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.19

2.20

2.8

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

100

2.00

2.20

1.3

1.5

—

(21494815) CD4 cells/100 lymphocytes in Specimen

584

1.39

2.18

3.0

2.3

37.7

41.6

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

2.24

2.17

3.4

1.7

37.8

56.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.24

2.17

1.0

1.1

umol/24h

1.7

0.06

(3023410) Appearance of Cerebral spinal fluid

644

1.37

2.16

3.1

1.5

—

(3029075) Extractable nuclear Ab panel - Serum

173

1.74

2.16

1.1

1.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

115

1.92

2.15

1.2

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

155

1231

1.26

2.14

1.7

1.6

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

663

1.36

2.13

1.3

1.5

28.9

27.6

0.12

418

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

152

1205

1.27

2.13

1.2

u/ml

47.2

37.2

—

119

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

282

1.56

2.13

1.8

1.6

nmol/l

2.9

13.5

0.69

239

(3015350) Toxocara sp Ab [Presence] in Serum

5.00

2.07

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

5.00

2.07

1.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

206

1.65

2.06

1.2

g/l

0.3

1.71

167

(3001893) Eosinophils/100 leukocytes in Pleural fluid

245

1.59

2.06

1.3

1.4

1.9

2.4

0.32

207

(37021550) Renin [Units/volume] in Plasma --upright

146

1.78

2.05

1.4

1.3

mu/l

114.4

57.0

0.60

109

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

4.00

2.04

1.2

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.11

2.02

1.2

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.11

2.02

1.0

—

(3028433) Virus identified in Specimen by Culture

231

1.60

2.01

1.4

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.63

2.00

10.5

5.0

—

(3050794) Legionella sp Ab [Presence] in Serum

2.22

2.00

1.0

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

205

1694

1.22

1.99

1.2

u/ml

17.2

39.6

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

114

880

1.30

1.99

1.4

1.6

57.5

61.7

0.53

566

(3026389) Candida sp identified in Specimen by Organism specific culture

113

872

1.30

1.98

1.3

—

(3020650) Glucose [Presence] in Urine

163

1.72

1.97

1.6

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

191

1570

1.22

1.96

1.2

1.3

u/ml

11.2

6.4

0.36

245

(3044009) aPTT.lupus sensitive (LA screen)

2.35

1.94

1.1

1.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.96

1.93

5.6

8.4

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.11

1.91

1.1

1.2

ug/l

72.9

108.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

356

1.46

1.89

1.1

1.2

ratio

1.1

0.57

118

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

204

1.62

1.88

2.8

3.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

157

1271

1.24

1.87

1.2

u/ml

1.8

3.3

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

114

1.84

1.86

1.5

1.2

76.4

76.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

127

1004

1.27

1.86

1.3

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.09

1.86

1.6

1.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

159

1.70

1.84

1.2

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

3.53

1.83

1.3

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.50

1.83

1.4

1.3

umol/24h

540.5

359.5

—

(3051101) Glucose [Moles/volume] in Cord blood

130

1.77

1.81

6.3

6.8

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

494

1.38

1.80

3.2

2.1

13.0

14.3

0.34

208

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

191

1.63

1.80

1.4

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

452

1.40

1.80

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

452

1.40

1.80

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.57

1.80

2.4

1.6

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

187

1550

1.21

1.79

1.2

1.3

u/ml

1.8

2.8

1.64

159

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.92

1.79

1.3

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

453

1.39

1.78

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

686

0.70

1.73

1.1

u/ml

2.5

4.2

0.93

264

(3025886) Oxalate [Mass/time] in 24 hour Urine

3.85

1.71

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

448

1.39

1.71

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

448

1.39

1.71

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.13

1.71

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

202

1.59

1.70

7.1

7.4

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

449

1.38

1.69

1.1

—

(21494434) Karyotype in Bone marrow

612

1.33

1.69

1.1

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

467

1.37

1.67

3.4

2.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

227

1.54

1.67

1.7

2.0

ug/l

65.1

62.1

0.10

222

(3000060) B lymphocytes [#/volume] in Blood

149

1.68

1.66

5.5

2.3

e6/l

193.8

750.0

0.59

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

188

1.60

1.65

1.8

1.5

ug/l

9.8

9.2

0.34

188

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

330

0.57

1.65

1.3

1.4

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.80

1.65

2.1

1.7

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

112

1.79

1.64

1.4

1.2

76.3

78.5

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

211

1788

1.18

1.63

1.9

pmol/l

195.6

203.5

0.55

196

1690

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.84

1.61

3.7

6.2

ug/min

83.4

43.3

1.17

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

174

1.61

1.60

1.3

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.00

1.59

1.1

—

(3047189) Immunofixation for 24 hour Urine

362

1.41

1.58

1.4

1.7

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

337

1.43

1.58

1.1

1.3

50.4

65.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

459

5102

0.89

1.57

1.4

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

419

0.64

1.51

1.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

291

1.45

1.49

1.1

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

631

0.71

1.49

1.0

u/ml

1.4

0.6

0.24

142

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.90

1.49

1.1

—

(3007461) Platelets [#/volume] in Blood

7687

76179

1.08

1.48

40.5

20.9

e9/l

250.5

244.9

8.85

7532

74073

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

410

1.37

1.47

2.6

2.7

34.9

36.9

0.26

139

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

522

1.32

1.47

1.5

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

239

2073

1.16

1.42

1.4

iu/l

25.0

29.4

1.38

194

1760

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

213

1.50

1.40

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

136

0.44

1.39

3.3

2.9

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

713

1.26

1.38

1.6

1.3

u/l

22.8

28.1

1.06

582

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

206

1.51

1.37

1.1

1.2

—

(3036603) Volume of Urine

459

1.33

1.37

1.9

1.7

1633.0

1907.3

0.74

113

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

455

0.68

1.35

1.3

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

163

0.49

1.35

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

437

3954

1.11

1.35

1.7

1.6

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

207

1.50

1.34

1.7

1.2

umol/l

3.1

4.3

1.35

192

(3035941) MCH [Entitic mass]

7687

76222

1.07

1.34

40.3

20.8

30.4

0.80

7595

75008

(3024731) MCV [Entitic volume]

7687

76223

1.07

1.34

40.4

20.8

91.4

91.2

2.89

7596

75010

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.97

1.32

2.7

1.5

umol/l

53.2

39.5

0.37

(1002224) Polysomnography panel

242

2762

0.87

1.31

1.1

—

(3026361) Erythrocytes [#/volume] in Blood

7687

76234

1.07

1.30

40.5

20.9

e12/l

4.4

4.5

108.99

7494

73893

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

473

1.31

1.28

1.8

—

(3010813) Leukocytes [#/volume] in Blood

7688

76255

1.07

1.27

40.5

20.9

e9/l

7.6

6.7

25.99

7502

73889

(3019174) dRVVT (LA screen)

2.00

1.27

1.1

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

122

1.64

1.27

1.6

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

135

0.44

1.26

6.7

5.8

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.29

1.26

1.5

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

272

2406

1.13

1.25

1.7

1.8

nmol/l

39.7

41.0

0.46

265

2327

(3014133) Dog dander IgE Ab [Units/volume] in Serum

746

0.76

1.25

1.1

u/ml

4.5

3.4

0.21

282

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

154

1.56

1.25

1.2

pmol/l

222.3

237.1

0.13

113

(40768793) Breast Pathology biopsy report

1190

0.81

1.24

1.4

1.3

—

(3000963) Hemoglobin [Mass/volume] in Blood

7687

76254

1.07

1.24

40.8

21.0

g/l

131.2

136.6

154.20

7590

75043

(3010726) Horse dander IgE Ab [Units/volume] in Serum

867

0.78

1.23

1.1

u/ml

1.5

2.4

0.44

197

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

179

1.51

1.23

1.3

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

2.16

1.21

1.1

1.0

—

(44806420)

196

1.48

1.21

2.0

2.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.72

1.21

1.3

1.2

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

172

1.51

1.20

3.5

6.3

56.3

71.2

1.30

137

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

194

1684

1.16

1.19

1.4

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.75

1.18

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

602

0.75

1.17

1.2

1.5

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.70

1.17

1.4

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

174

1503

1.16

1.15

2.2

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

1.81

1.14

2.5

3.4

mg/l

1.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.85

1.13

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.85

1.13

1.0

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7014

69439

1.05

1.12

5.6

5.0

mmol/l

2.5

2.7

69.08

6454

63892

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

233

0.60

1.11

1.5

1.8

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

741

6939

1.07

1.10

1.6

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

512

1.27

1.10

1.2

u/ml

17.6

40.6

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

176

1.48

1.09

6.6

7.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

410

3749

1.10

1.08

1.2

iu/ml

125.1

133.7

0.19

125

1374

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.19

1.08

1.1

1.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

269

1.38

1.08

1.0

98.7

96.5

0.18

208

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.12

1.05

2.9

1.7

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

697

1.22

1.03

1.4

e6/l

264345.8

111064.7

0.69

480

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

607

1.24

1.02

1.7

1.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

299

0.67

1.01

1.2

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

139

1.51

0.99

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

308

1.33

0.99

3.1

3.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.71

0.98

1.2

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

156

1.48

0.98

2.1

1.7

—

(4034850)

253

2271

1.12

0.97

14.9

9.8

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

802

1.20

0.97

1.1

u/ml

4.1

3.2

0.38

367

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.67

0.97

1.1

1.0

ug/l

85.9

78.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.95

0.97

1.0

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.63

0.97

1.0

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.74

0.96

9.7

2.1

—

(4024509)

631

1.22

0.95

1.9

1.5

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

0.00

0.95

0.0

5.5

—

0.8

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.77

0.94

1.0

1.8

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

111

1301

0.85

0.94

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

195

2195

0.89

0.93

1.5

1.7

mg/l

5.6

3.6

1.18

170

1564

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1062

0.84

0.93

1.1

u/ml

1.7

1.6

0.05

414

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

167

1.44

0.91

1.4

1.1

—

(3008898) HLA-B27 [Presence]

216

1931

1.12

0.91

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.91

0.88

1.0

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

333

1.29

0.87

1.3

1.5

5.7

3.5

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

221

1.36

0.85

1.2

1.3

37.4

23.7

—

(3008536) Aspergillus sp Ab [Presence] in Serum

146

1.44

0.82

2.4

2.3

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.88

0.81

1.2

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.88

0.81

14.3

9.0

—

(3028717) Thiamine [Mass/volume] in Blood

1.64

0.81

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

178

1588

1.12

0.80

1.2

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.70

0.80

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

181

1.38

0.79

1.3

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

181

1.38

0.79

1.4

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

130

1138

1.14

0.79

1.7

1.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

208

1.35

0.77

1.1

—

(4211845)

340

1.27

0.77

3.2

3.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

824

0.84

0.77

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

787

1.17

0.76

1.3

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

157

1.40

0.76

1.0

1.1

—

(3013762) Body weight Measured

0.00

0.76

0.0

1.3

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

132

1.44

0.75

1.1

u/ml

67.0

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

952

0.85

0.75

1.1

u/ml

5.5

4.7

0.14

461

(3014891) Appearance of Pleural fluid

1.52

0.75

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

724

0.83

0.75

1.6

1.5

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.64

0.73

7.0

11.0

—

(3051593) INR in Capillary blood by Coagulation assay

361

1.25

0.72

3.7

10.9

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.80

0.72

1.0

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

281

1.28

0.72

1.1

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.52

0.72

1.6

1.9

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

194

1.34

0.71

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.85

0.68

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.56

0.68

1.3

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

823

0.85

0.67

1.3

1.2

mmol/l

7.9

7.5

0.39

604

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

474

1.20

0.67

1.4

1.5

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

179

1.34

0.66

1.4

1.3

39.3

33.7

0.28

118

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

659

0.83

0.66

1.5

1.4

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.72

0.64

1.0

1.1

nmol/l

276.4

248.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

524

1.18

0.63

3.3

5.0

u/ml

68.8

76.6

0.10

158

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

225

1.29

0.62

2.5

1.9

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

279

1.26

0.62

1.3

1.1

—

(4212803)

1.55

0.62

1.1

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.63

0.62

4.5

3.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.60

0.61

1.4

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

280

1.25

0.60

1.6

2.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.60

0.0

1.1

—

2.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

662

0.84

0.60

1.5

1.4

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.50

0.59

1.3

1.1

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

0.00

0.59

0.0

1.5

—

37.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

661

0.85

0.59

1.5

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

593

1.16

0.59

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

677

1.15

0.58

1.6

1.4

nmol/l

0.2

0.3

0.82

523

(3000285) Sodium [Moles/volume] in Blood

1.44

0.58

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

660

0.85

0.58

1.5

1.4

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.51

0.58

1.0

1.1

—

(4094501)

184

2009

0.91

0.58

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

916

0.87

0.58

1.1

u/ml

1.0

1.3

0.13

371

(3024263) Appearance of Synovial fluid

410

1.20

0.57

1.7

—

(44806071)

1.48

0.57

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

256

2380

1.08

0.56

1.9

2.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

878

1.13

0.55

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

477

1.18

0.54

1.1

mg/l

253.3

289.9

0.75

412

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.50

0.54

1.0

1.1

—

(4133840)

195

1.28

0.54

1.0

1.2

—

(4027681)

367

1.20

0.54

1.3

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.62

0.52

1.0

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

379

1.19

0.50

1.1

nmol/l

3.9

9.9

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.46

0.50

1.2

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.49

0.49

1.7

2.5

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

367

0.82

0.48

1.6

1.5

ug/l

2.1

4.2

1.43

300

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

154

1.30

0.48

1.4

1.2

—

(3016228) CD19 cells/100 cells in Blood

290

1.21

0.47

1.7

2.0

8.4

8.0

0.11

280

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.46

0.46

1.0

—

(44813793)

402

1.17

0.46

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

684

1.13

0.45

1.1

1.2

—

(40765096) Chromosome analysis panel by Banding

219

1.23

0.45

1.2

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6793

67551

1.03

0.44

5.0

4.4

mmol/l

1.3

1.4

89.49

6218

62125

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

497

1.15

0.44

1.2

mg/l

34.5

41.8

0.99

404

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

256

1.21

0.44

2.0

2.8

umol/l

29.6

28.8

0.10

193

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

121

1.32

0.44

2.5

3.1

ng/l

108.6

149.8

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

432

1.16

0.44

1.4

1.3

u/ml

1.9

1.5

0.12

206

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.61

0.43

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

859

1.11

0.42

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

230

1.22

0.42

1.7

1.9

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.63

0.42

1.0

1.4

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.38

0.41

7.5

5.4

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.52

0.41

2.4

1.2

—

(3051339) Copper [Moles/volume] in Blood

1.47

0.40

1.0

1.1

umol/l

15.0

16.4

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.47

0.40

1.0

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

168

1.25

0.40

1.2

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

159

1.26

0.40

1.3

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

214

1.22

0.39

1.2

1.5

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

106

1.32

0.39

1.6

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

106

1.32

0.39

1.6

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

106

1.32

0.39

1.5

1.2

—

(3022475) Manganese [Moles/volume] in Blood

1.35

0.37

1.4

1.6

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.35

0.37

1.2

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

662

0.89

0.36

1.3

1.4

pmol/l

67.4

109.0

0.43

219

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

6840

68080

1.02

0.36

5.1

4.5

mmol/l

4.4

4.6

61.26

6326

62973

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.40

0.35

1.5

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

227

1.19

0.34

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

254

0.83

0.34

1.0

1.1

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

1.33

0.33

3.0

1.5

nmol/l

3.5

4.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

205

2164

0.95

0.32

1.9

1.8

—

(3045142) Bone marrow Pathology biopsy report

817

1.09

0.32

1.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

143

0.77

0.32

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

137

1.24

0.32

1.4

1.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

230

0.83

0.31

1.2

g/l

40.6

40.0

—

116

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

175

0.80

0.30

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

175

0.80

0.30

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

175

0.80

0.30

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

175

0.80

0.30

1.0

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

200

1899

1.05

0.30

1.7

1.9

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

364

1.13

0.28

5.1

6.5

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

167

1.20

0.28

1.4

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

544

0.90

0.28

1.5

1.4

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.19

0.26

1.1

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

561

0.91

0.25

1.6

1.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

540

0.91

0.25

1.8

1.7

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

287

0.87

0.24

1.1

ng/l

1164.0

507.9

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

423

4109

1.03

0.24

1.3

au/ml

30.5

55.2

1.58

186

(3025130) Human papilloma virus identified in Specimen

571

1.09

0.23

2.0

1.7

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

284

1.13

0.23

1.6

2.0

ug/l

25.1

428.4

1.02

263

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

1.28

0.23

1.2

1.3

25.6

11.8

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

333

1.11

0.22

1.1

1.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

135

0.81

0.22

1.3

nmol/l

10.5

32.7

3.37

108

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.21

0.0

2.4

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.21

0.0

2.4

—

(46235168) Fasting glucose [Moles/volume] in Blood

1.22

0.21

1.3

3.6

mmol/l

8.4

7.9

—

(3001556) Androgen free Index in Serum or Plasma

1.16

0.21

1.4

1.2

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

316

1.11

0.20

1.1

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.25

0.20

1.5

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

927

1.06

0.20

1.1

—

(3005033) Fetal Nuchal fold Thickness US

541

0.92

0.19

1.5

1.4

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

118

1.19

0.19

1.8

3.3

—

(3003338) MCHC [Mass/volume]

5784

58049

0.99

0.18

36.0

18.2

g/l

331.8

332.9

13.34

5731

57554

(3041806) Other cells [#/volume] in Blood by Manual count

109

1.19

0.18

2.4

1.5

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.17

0.17

4.6

1.9

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.13

0.17

1.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

147

1413

1.04

0.17

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

715

7266

0.98

0.17

1.4

—

(3001729) Color of Synovial fluid

0.75

0.17

1.6

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

446

1.08

0.16

1.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

924

1.05

0.16

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

298

0.91

0.16

1.1

1.0

u/ml

0.2

2.8

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

158

1.14

0.16

1.2

1.1

—

(40762814) Titanium [Mass/volume] in Blood

129

0.85

0.14

2.6

2.2

ug/l

3.1

3.8

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

459

4508

1.02

0.14

2.5

2.4

au/ml

25.4

23.4

0.13

227

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

511

0.94

0.14

1.0

ng/l

321.3

325.4

0.04

361

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.82

0.13

1.6

1.9

—

(3025577) Chromium [Mass/volume] in Blood

459

0.94

0.13

2.2

2.0

ug/l

1.9

2.5

1.16

378

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

383

1.07

0.13

5.8

5.9

u/ml

1557.0

8802.7

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

374

1.07

0.13

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

355

0.93

0.12

1.1

iu/ml

15.1

11.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

104

1.15

0.12

1.2

1.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

337

1.07

0.11

1.0

1.1

u/l

1.1

0.07

165

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

269

1.08

0.11

1.4

1.2

—

(3026470) Cobalt [Mass/volume] in Blood

475

0.95

0.10

2.1

1.9

ug/l

3.3

3.5

0.12

407

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

1.11

0.09

1.2

1.3

28.2

31.7

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.11

0.09

1.2

1.1

—

(4015189)

203

1.08

0.09

2.0

2.2

—

(3024869) Neuronal Ab [Presence] in Serum

145

1.10

0.09

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

513

0.95

0.09

1.0

ng/l

45.8

43.4

0.18

355

(3005011) Chlamydia sp Ab [Titer] in Serum

1.13

0.09

1.6

1.7

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.83

0.08

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.82

0.08

1.0

1.1

u/l

7.6

14.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.06

0.08

1.0

—

(3022689) Creatine [Moles/volume] in Urine

205

1.07

0.07

1.4

1.5

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.83

0.07

1.2

2.8

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

510

0.96

0.07

1.0

ng/l

891.7

713.9

1.44

345

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.07

0.07

1.4

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.84

0.07

8.4

11.5

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

128

1.09

0.06

1.4

1.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

253

0.95

0.05

1.9

2.4

nmol/l

181.4

148.9

0.76

220

(3051387) C reactive protein [Mass/volume] in Capillary blood

154

1518

1.01

0.05

3.9

3.4

mg/l

27.1

28.2

0.15

104

954

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

353

0.96

0.04

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

170

1.06

0.04

3.0

1.5

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

220

1.05

0.03

1.3

1.5

mmol/l

9.3

8.1

0.62

131

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3085

30890

1.00

0.03

4.5

4.9

ug/l

3.0

3.3

0.16

2729

27760

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

142

1.06

0.02

7.5

7.4

—

(40758292) HTLV I+II Ab panel - Serum

116

0.95

0.00

1.3

1.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

247

1.01

0.00

1.2

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

130

1.00

0.00

1.0

—

(3015183) Erythrocyte sedimentation rate

290

1.00

0.00

1.1

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

166

1.02

0.00

1.2

1.3

—

(3048879) Bone marrow aspiration report

211

1.00

0.00

1.3

1.9

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.1

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.00

0.00

1.3

1.7

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.89

0.00

1.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.95

0.00

1.4

1.1

—

(3007916) DNA double strand Ab [Titer] in Serum

0.92

0.00

2.3

1.2

—

87.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.99

0.00

2.4

1.7

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.88

0.00

2.0

1.5

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.98

0.00

3.8

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.1

—

1725.6

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.5

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.02

0.00

1.0

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.98

0.00

11.4

4.5

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_ACUTPANC and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_ACUTPANC	1.589 [1.46, 1.73]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.269

During the follow-up period (1.1.1998 — 31.12.2019), 5212 out of 18384 females with K11_ACUTPANC died.

Males

Parameter	HR [95% CI]	p-value
K11_ACUTPANC	2.022 [1.84, 2.23]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.009

During the follow-up period (1.1.1998 — 31.12.2019), 7862 out of 25975 males with K11_ACUTPANC died.

Mortality risk

Mortality risk for people of age

years, who have K11_ACUTPANC.

N-year risk	Females	Males
1	0.138%	0.372%
5	0.92%	2.266%
10	2.36%	5.872%
15	4.55%	10.543%
20	8.059%	17.277%

Relationships between endpoints

↥

Index endpoint: K11_ACUTPANC – Acute pancreatitis

GWS hits: 7

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Acute pancreatitis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints